aspirin has been researched along with Angor Pectoris in 320 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of supplementing qi and activating blood circulation method (YQHX) on platelet aggregation rate (PAgR), platelet adhesion rate (PAdR) and thromboxane B2(TXB2) level in patients with stable angina pectoris and intolerable to aspirin." | 9.13 | [Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin]. ( Chen, KY; Gao, L; Li, YJ, 2008) |
| "Aspirin resistance may increase the risk of major adverse cardiac events (MACE) more than threefold in patients with stable coronary artery disease (CAD)." | 9.12 | Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). ( Mercanoglu, F; Meric, M; Nisanci, Y; Oflaz, H; Oncul, A; Onur, I; Ozcan, M; Pamukcu, B; Umman, B, 2007) |
| "Clinical trials have demonstrated a prophylactic role for aspirin in myocardial infarction and in unstable angina pectoris." | 9.07 | Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. ( Edvardsson, N; Jahnmatz, B; Juul-Möller, S; Omblus, R; Rosén, A; Sørensen, S, 1992) |
| "The objective of this study was to examine the effect of low-dose aspirin (325 mg on alternate days) on the primary prevention of angina pectoris in the United States Physicians' Health Study." | 9.06 | Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. ( Buring, JE; Gaziano, JM; Goldhaber, SZ; Grobbee, DE; Hennekens, CH; Manson, JE; Ridker, PM; Stampfer, MJ; Taylor, JO, 1990) |
| " Although a 150 mg dose of aspirin reduced urinary dinor-TxB2 levels by over 75 per cent, it had no effect on the course of the chronic recurrent form of angina pectoris due to vasospasm ("vasotonic angina")." | 9.05 | Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. ( FitzGerald, GA; Friesinger, GC; Maas, RL; Oates, JA; Roberts, LJ; Robertson, D; Robertson, RM, 1981) |
| " This study was designed to determine the relation between responses to aspirin and clopidogrel as assessed by a point-of-care assay (Verify Now, Accumetrics, San Diego, California) and periprocedural myocardial infarction (PMI) in patients undergoing elective PCI for stable angina." | 7.74 | Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. ( Barbato, E; Bartunek, J; Cuisset, T; De Bruyne, B; Hamilos, M; Sarma, J; Sarno, G; Vanderheyden, M; Wijns, W; Wyffels, E, 2008) |
| " A patient suffering from coronary artery disease and taking metoprolol and aspirin was stung by wasps and developed cutaneous allergic signs including rash, urticaria and orbital oedema." | 7.74 | Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration. ( Ioannidis, TI; Karpeta, MZ; Kounis, GN; Kounis, NG; Mazarakis, A; Notaras, SP; Rallis, DG; Tsintoni, AC, 2007) |
| " All suffered stent thrombosis after discontinuation (in three cases prematurely) of clopidogrel therapy." | 7.73 | [Thrombosis of a coronary stent after discontinuing treatment with clopidogrel]. ( de Boer, MJ; Hautvast, RW; Heestermans, AA; Jaarsma, W; ten Berg, JM; van Werkum, JW, 2006) |
| "Between September 1999 and April 2002, a total of 1,236 patients hospitalized for acute coronary syndrome (ACS) were questioned in order to determine whether aspirin intake had been interrupted." | 7.73 | Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. ( Benhamou, M; Cerboni, P; Ferrari, E; Marcel, B, 2005) |
| "Between 1950 and 1975, 473 Rochester patients had the diagnosis of rheumatoid arthritis and received aspirin treatment." | 7.66 | Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. ( Fuster, V; Kurland, LT; Linos, A; O'Fallon, W; Whisnant, JP; Worthington, JW, 1978) |
| "When ticlopidine was given for 72 hours, TF levels were similar to normal laboratory values both in stable and unstable patients." | 6.69 | Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris. ( Ariëns, RA; Bernies, M; Bossi, IM; Brambilla, GM; Donatelli, F; Fajadet, J; Gregorini, L; Marco, I; Marco, J; Mari, D; Romano, SM; Somalvico, F, 2000) |
| " On the basis of present information it is evident that, in addition to heparin, all patients suffering from suspected acute myocardial infarction should receive immediate low dose aspirin which should be continued for one to six months." | 6.16 | Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategies. ( McGregor, M; Silberberg, JS, 1989) |
| " Conditions characterized by a reduction in platelet survival and where dipyridamole has been used include heart valve replacement, arterial grafting, cerebrovascular disorders, and disorders of peripheral circulation." | 6.15 | Dipyridamole: a critical evaluation. ( Alexander, MR; Rivey, MP; Taylor, JW, 1984) |
| "Aspirin was given as 160 mg/day and clopidogrel as 300 mg loading dose followed by 75 mg/day." | 5.35 | Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris. ( Agewall, S; Berglund, M; Gordon, A; Saha, S; Sylvén, C, 2008) |
| "Definite/probable ST and MB (TIMI major and Bleeding Academic Research Consortium (BARC) ≥ 3) were compared in 2 subsequent trials with similar inclusion criteria but different DAPT duration, that is, BASKET (6 months; n = 557) and BASKET-PROVE (12 months; n = 2,314), between months 0 to 6 (DAPT in both trials), 7 to 12 (DAPT in BASKET-PROVE only), and 13 to 24 (aspirin in both trials) using propensity score-adjusted, time-stratified Cox proportional hazard models." | 5.19 | Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. ( Alber, H; Bonetti, PO; Eberli, F; Erne, P; Galatius, S; Jeger, RV; Kaiser, CA; Pedrazzini, G; Pfisterer, ME; Rickli, H; Sørensen, R; von Felten, S, 2014) |
| "We assessed in a prospective and randomized study the benefit of higher dose of aspirin, in association with clopidogrel, on aspirin response and non COX-specific platelet testing in patients receiving Drug Eluting Stent (DES) for stable angina pectoris." | 5.14 | Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study. ( Bali, L; Bonnet, JL; Cuisset, T; Frere, C; Gaborit, B; Lambert, M; Morange, PE; Moro, PJ; Mouret, JP; Quilici, J; Uhry, S, 2009) |
| "To investigate the effects of supplementing qi and activating blood circulation method (YQHX) on platelet aggregation rate (PAgR), platelet adhesion rate (PAdR) and thromboxane B2(TXB2) level in patients with stable angina pectoris and intolerable to aspirin." | 5.13 | [Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin]. ( Chen, KY; Gao, L; Li, YJ, 2008) |
| "Aspirin resistance may increase the risk of major adverse cardiac events (MACE) more than threefold in patients with stable coronary artery disease (CAD)." | 5.12 | Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). ( Mercanoglu, F; Meric, M; Nisanci, Y; Oflaz, H; Oncul, A; Onur, I; Ozcan, M; Pamukcu, B; Umman, B, 2007) |
| " Thirty-nine patients with angina pectoris who were scheduled for coronary stent implantation were assigned to either group 1 (160 mg aspirin + 500 mg ticlopidine post-stent), group 2 (160 mg aspirin + abciximab + 500 mg ticlopidine post-stent) or group 3 (160 mg aspirin + loading dose (375/450 mg) clopidogrel pre-stent and 75 mg clopidogrel post-stent)." | 5.10 | Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention. ( Bosmans, JM; Claeys, MJ; Dilling, D; Michiels, JJ; Van Der Planken, MG; Vertessen, F; Vrints, CJ, 2002) |
| "5 and 75 mg of aspirin per day each reduced the incidence of coronary heart disease (CHD)." | 5.10 | Antithrombotic treatment and the incidence of angina pectoris. ( Brennan, PJ; Knottenbelt, C; Meade, TW, 2002) |
| "The second European Stroke Prevention Study investigated the prevention of stroke and/or death in 6602 patients with transient ischaemic attack or stroke with aspirin (25 mg b." | 5.09 | Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). ( Bertrand-Hardy, JM; Darius, H; Diener, HC; Humphreys, M, 2001) |
| "Clinical trials have demonstrated a prophylactic role for aspirin in myocardial infarction and in unstable angina pectoris." | 5.07 | Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. ( Edvardsson, N; Jahnmatz, B; Juul-Möller, S; Omblus, R; Rosén, A; Sørensen, S, 1992) |
| "Our data indicated that alternate-day aspirin therapy greatly reduced the risk for first myocardial infarction among patients with chronic stable angina, a group of patients at high risk for cardiovascular death (P less than 0." | 5.07 | Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. ( Buring, JE; Gaziano, JM; Hennekens, CH; Manson, JE; Ridker, PM, 1991) |
| "The objective of this study was to examine the effect of low-dose aspirin (325 mg on alternate days) on the primary prevention of angina pectoris in the United States Physicians' Health Study." | 5.06 | Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. ( Buring, JE; Gaziano, JM; Goldhaber, SZ; Grobbee, DE; Hennekens, CH; Manson, JE; Ridker, PM; Stampfer, MJ; Taylor, JO, 1990) |
| "We tested the usefulness of aspirin (325 mg twice daily), heparin (1000 units per hour by intravenous infusion), and a combination of the two in the early management of acute unstable angina pectoris in a double-blind, randomized, placebo-controlled trial involving 479 patients." | 5.06 | Aspirin, heparin, or both to treat acute unstable angina. ( deGuise, P; Joly, P; Juneau, M; Latour, JG; Lévy, G; McCans, J; Ouimet, H; Pelletier, E; Stasiak, J; Théroux, P, 1988) |
| " Although a 150 mg dose of aspirin reduced urinary dinor-TxB2 levels by over 75 per cent, it had no effect on the course of the chronic recurrent form of angina pectoris due to vasospasm ("vasotonic angina")." | 5.05 | Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. ( FitzGerald, GA; Friesinger, GC; Maas, RL; Oates, JA; Roberts, LJ; Robertson, D; Robertson, RM, 1981) |
| "A randomized, double-blind clinical trial in 1266 men with unstable angina showed that 324 mg of aspirin daily for 12 weeks reduced the incidence of myocardial infarction by 51% (p = ." | 5.05 | Unstable angina: status of aspirin and other forms of therapy. ( Lewis, HD, 1985) |
| " Meta-analyses revealed that aspirin in combination with FDD was significantly more effective at alleviating angina pectoris and improving electrocardiogram (ECG) results relative to aspirin therapy alone, reflected by the summary effects for the clinical markedly effective (OR = 2." | 4.93 | Clinical Therapeutic Effects of Aspirin in Combination with Fufang Danshen Diwan, a Traditional Chinese Medicine Formula, on Coronary Heart Disease: A Systematic Review and Meta-Analysis. ( He, J; Huang, J; Kong, X; Tang, X; Ye, F, 2016) |
| "Using the key terms acute coronary syndrome, atherothrombosis, ischemic stroke, myocardial infarction, MI, peripheral arterial disease, TIA, transient ischemic attack, unstable angina,aspirin,ticlopidine,dipyridamole, and clopidogrel, we searched the MEDLINE database as well as the trial register of the Cochrane Groups to identify studies published from 1960 to August 2004." | 4.82 | Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. ( Anand, SS; Tran, H, 2004) |
| " In elective de novo lesions has shown remarkably clear lumens at follow-up angiography and intravascular ultrasound within the stented segments were observed with no lesion progression at the stent margins or thrombosis after a 2 month regimen of aspirin, and ticlopodine or clopidogrel." | 4.81 | Sirolimus-eluting stents: a review of experimental and clinical findings. ( Albiero, R; Colombo, A; Corvaja, N; Di Mario, C; Falotico, R; Stankovic, G; Takagi, T; Toutouzas, K, 2002) |
| " Strategies used for plaque stabilisation resulting in a reduction in cardiovascular mortality and morbidity are: smoking cessation; aspirin (acetylsalicylic acid); blood pressure control; lipid lowering agents when low density lipoprotein cholesterol is elevated despite dietary therapy; coronary bypass surgery in patients with left main stem disease or triple vessel coronary disease and diminished left ventricular function; and use of estrogen in postmenopausal women." | 4.80 | Choosing the most appropriate treatment for stable angina. Safety considerations. ( Asirvatham, S; Sebastian, C; Thadani, U, 1998) |
| "Aspirin showed significant benefits when administered in patients with acute myocardial infarction or unstable angina, and also when used for secondary prevention in patients with known coronary artery disease." | 4.80 | [Aspirin and prevention of cardiovascular risk]. ( Gabriel Steg, P; Karila-Cohen, D, 2000) |
| "The primary drugs utilized in the treatment of angina pectoris include organic nitrates, beta-adrenoceptor antagonists, Ca2+ antagonists, and the antithrombotic agents aspirin and heparin." | 4.79 | Pharmacologic therapy of angina pectoris. ( Bueno, O; Zavecz, JH, 1995) |
| " For primary prevention, aspirin showed no effect in a British study, but reduced the incidence of myocardial infarction by 44% per year in an American trial concerning men and by 32% concerning women." | 4.79 | [Blood thinning in heart patients]. ( Meier, B, 1995) |
| " These studies, in conjunction with recent histopathologic studies demonstrating plaque defects and overlying thrombosis in patients with unstable ischemia and sudden death, suggest a common mechanism for unstable angina and myocardial infarction and strongly support the rationale for antithrombotic therapy with heparin and with aspirin in the management of patients with unstable angina." | 4.77 | Thrombosis in unstable angina: angiographic aspects. ( Cowley, MJ; DiSciascio, G; Rehr, RB, 1987) |
| "Eighty-two consecutive patients with stable angina pectoris who received Resolute zotarolimus-eluting stents (R-ZESs; Medtronic Cardiovascular, Santa Rosa, CA, USA) were enrolled." | 3.88 | Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy. ( Fujimoto, W; Kawai, H; Miyata, T; Oishi, S; Onishi, T; Osue, T; Sawada, T; Shimane, A; Takahashi, Y; Takaya, T; Taniguchi, Y; Toba, T; Yasaka, Y, 2018) |
| "In patients with coronary artery disease (CAD), though aspirin inhibits platelet activation and reduces atherothrombotic complications, it does not always sufficiently inhibit platelet function, thereby causing a clinical situation known as aspirin resistance." | 3.83 | Does high serum uric acid level cause aspirin resistance? ( Alihanoglu, YI; Bilgin, M; Ergin, A; Esin, F; Evrengul, H; Kaftan, HA; Kilic, ID; Ozkan, E; Ozkan, H; Yildiz, BS, 2016) |
| "The authors studied efficacy of the generic clopidogrel Еgithromb manufactured by EGIS PHARMACEUTICALS (Hungary) based on clinical data and parameters of light aggregometry in a total of 30 patients subjected to planned subcutaneous coronary intervention for stable angina pectoris." | 3.79 | [Assessment of clinical and antiaggregation efficacy of generic clopidogrel 'Egithromb' in roentgenosurgical practice]. ( Faĭl', IL; Loenko, VB; Smialovskiĭ, DV; Sorokina, EA, 2013) |
| " A patient suffering from coronary artery disease and taking metoprolol and aspirin was stung by wasps and developed cutaneous allergic signs including rash, urticaria and orbital oedema." | 3.74 | Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration. ( Ioannidis, TI; Karpeta, MZ; Kounis, GN; Kounis, NG; Mazarakis, A; Notaras, SP; Rallis, DG; Tsintoni, AC, 2007) |
| " This study was designed to determine the relation between responses to aspirin and clopidogrel as assessed by a point-of-care assay (Verify Now, Accumetrics, San Diego, California) and periprocedural myocardial infarction (PMI) in patients undergoing elective PCI for stable angina." | 3.74 | Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. ( Barbato, E; Bartunek, J; Cuisset, T; De Bruyne, B; Hamilos, M; Sarma, J; Sarno, G; Vanderheyden, M; Wijns, W; Wyffels, E, 2008) |
| " All suffered stent thrombosis after discontinuation (in three cases prematurely) of clopidogrel therapy." | 3.73 | [Thrombosis of a coronary stent after discontinuing treatment with clopidogrel]. ( de Boer, MJ; Hautvast, RW; Heestermans, AA; Jaarsma, W; ten Berg, JM; van Werkum, JW, 2006) |
| "Between September 1999 and April 2002, a total of 1,236 patients hospitalized for acute coronary syndrome (ACS) were questioned in order to determine whether aspirin intake had been interrupted." | 3.73 | Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. ( Benhamou, M; Cerboni, P; Ferrari, E; Marcel, B, 2005) |
| "The in vitro effect of acetylsalicylic acid (ASA) on fibrin gel lysis by exogenous t-PA was studied in 13 patients with angina pectoris." | 3.69 | The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator. ( Blombäck, M; Fatah, K; Ivert, T; Williams, S, 1995) |
| " There were 12 independent significant predictors for readmission: clinical history (a previous history of either congestive heart failure or myocardial infarction, or CABG); acute operation; postoperative complications (time in intensive care unit greater than two days, neurological complications); clinical findings four to seven days after the operation (arrhythmia, systolic murmur equivalent to mitral regurgitation); medication four to seven days after the operation (antidiabetics, diuretics for heart failure, other antiarrhythmics (other than beta blockers, calcium antagonists, and digitalis), and lack of treatment with aspirin)." | 3.69 | Predictors of hospital readmission two years after coronary artery bypass grafting. ( Albertsson, P; Brandrup-Wognsen, G; Emanuelsson, H; Haglid, M; Hartford, M; Herlitz, J; Hjalmarson, A; Karlson, BW; Karlsson, T; Sandén, W, 1997) |
| "N-Acetylcysteine (N-AC) potentiates the systemic and coronary hemodynamic and antianginal effects of nitroglycerin (NGT) in humans; NTG/N-AC reduces the incidence of acute myocardial infarction in patients with unstable angina pectoris." | 3.69 | N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation. ( Chirkov, YY; Horowitz, JD, 1996) |
| "The effects of aspirin on coronary hemodynamics and transcardiac concentrations of thromboxane B2 (the stable metabolite of thromboxane A2) were determined at rest and during pacing-induced myocardial ischemia in 11 patients with coronary disease." | 3.67 | Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia. ( Addonizio, VP; Fisher, CA; Harken, AH; Hirshfeld, JW; Laskey, WK; Martin, JL; Untereker, WJ, 1985) |
| " This study describes the consequences of acute prostaglandin synthesis inhibition on the hemodynamic effects of nitroglycerin in patients with stable angina pectoris." | 3.67 | [Hemodynamic effects of nitroglycerin following acute inhibition of prostaglandin synthesis]. ( Punzengruber, C; Silberbauer, K; Sinzinger, H, 1986) |
| "Between 1950 and 1975, 473 Rochester patients had the diagnosis of rheumatoid arthritis and received aspirin treatment." | 3.66 | Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. ( Fuster, V; Kurland, LT; Linos, A; O'Fallon, W; Whisnant, JP; Worthington, JW, 1978) |
| "Side effects, such as arrhythmia, angina pectoris, and nervous headache, were observed in the celecoxib 400 mg/d group." | 2.72 | [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis]. ( Geng, HG; Li, SR; Sheng, JQ; Su, H; Yan, W; Yang, XY; Yu, DL; Zhang, YH, 2006) |
| " It is not clear if combining enoxaparin with glycoprotein IIb/IIIa inhibitors is as safe or as effective as the current standard combination of unfractionated heparin with glycoprotein IIb/IIIa inhibitors." | 2.71 | Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. ( Ardissino, D; Bilheimer, DW; Blazing, MA; Braunwald, E; Califf, RM; de Lemos, JA; DiBattiste, PM; Fox, KA; Gardner, LH; Hasselblad, V; Lewis, EF; Palmisano, J; Pfeffer, MA; Ramsey, KE; Snapinn, SM; Verheugt, FW; White, HD, 2004) |
| "Treatment with sarpogrelate in addition to aspirin and ticlopidine caused no major adverse cardiovascular events or hemorrhagic adverse effects during the 6-month follow-up period." | 2.71 | Sarpogrelate treatment reduces restenosis after coronary stenting. ( Fujita, M; Ho, M; Ishii, K; Miki, O; Miwa, K; Miyamoto, A; Mizuno, K; Tsukahara, R, 2003) |
| "When ticlopidine was given for 72 hours, TF levels were similar to normal laboratory values both in stable and unstable patients." | 2.69 | Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris. ( Ariëns, RA; Bernies, M; Bossi, IM; Brambilla, GM; Donatelli, F; Fajadet, J; Gregorini, L; Marco, I; Marco, J; Mari, D; Romano, SM; Somalvico, F, 2000) |
| "83%) and greater average stenosis of worst lesions at 6 months (74% vs." | 2.68 | Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs AC ( Folland, ED; Hartigan, PM; Parisi, AF, 1997) |
| "We conclude that patients with unstable angina pectoris have a similar outcome after two years whether they receive medical therapy alone or coronary bypass surgery plus medical therapy." | 2.66 | Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. ( Deupree, RH; Luchi, RJ; Scott, SM, 1987) |
| "The protocols varied widely in terms of medication and dosing choices, as well as listed contraindications to treatments." | 2.52 | Chest Pain of Suspected Cardiac Origin: Current Evidence-based Recommendations for Prehospital Care. ( Barger, JA; Brown, JF; Gilbert, GH; Koenig, KL; Rudnick, EM; Salvucci, AA; Savino, PB; Sporer, KA, 2015) |
| "The incidence of deep vein thrombosis or pulmonary embolism in more than 500 patients undergoing hip surgery was similar for these 3 treatments." | 2.40 | Triflusal. ( Goa, KL; McNeely, W, 1998) |
| "Thromboxane A2 is a potent stimulator of platelet aggregation and vasoconstriction and synthesis may be completely inhibited by a single oral dose of 150 mg acetylsalicylic acid or an intravenous dose of 100 mg." | 2.39 | Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction). ( Husted, SE; Vissinger, H; Winther, K, 1994) |
| "Unstable angina is a clinical syndrome characterized by increased rate and severity of angina pectoris attacks and, sometimes but not always, accompanied by ECG changes similar to those seen in coronary insufficiency." | 2.38 | Unstable angina: pathophysiology and drug therapy. ( Bleifeld, W, 1990) |
| "Five patients (5." | 1.51 | [The Pathways to Increase the Efficacy of Drug Therapy in Patients with Ischemic Heart Disease after Coronary Artery Bypass Grafting]. ( Barbarash, OL; Hryachkova, ON; Kashtalap, VV; Shibanova, IA; Zykov, MV, 2019) |
| "Although depressive disorders have been associated with increased risk of worse outcomes with cardiovascular diseases (CVDs), its relation with access to and quality of cardiovascular care is not well studied." | 1.48 | Impact of Depressive Disorder on Access and Quality of Care in Veterans With Prevalent Cardiovascular Disease. ( Butler, J; Lacey, M; Parikh, PB; Shroyer, AL; Srivastava, P, 2018) |
| "Aspirin resistance was defined as the mean platelet aggregation of > or = 70% with 10 mM ADP and the mean platelet aggregation of > or = 20% with 0." | 1.39 | Aspirin resistance in Thai patients with chronic stable angina. ( Chinthammitr, Y; Chotinaiwattarakul, C; Karevee, D; Panchavinnin, P; Phankingthongkum, R; Sumalee, C; Tresukosol, D; Tungsubutra, W; Wongpraparut, N, 2013) |
| "Stroke is an important clinical problem and some strokes are caused by a cardiac thrombus." | 1.39 | 64-MDCT can depict the thrombi expanded from the left lower pulmonary vein to the left atrium in the patient with angina pectoris. ( Takeuchi, H, 2013) |
| "Aspirin resistance was measured by urinary 11-dehydro-thromboxane beta-concentrations with an enzyme immunoassay kit." | 1.38 | Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors. ( Darabian, M; Eskandarian, R; Ghorbani, R; Heshmatnia, J, 2012) |
| "Incidence of postoperative hemorrhage (early and delayed) was not significant (P = ." | 1.37 | Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications. ( Bariol, SV; Brooks, AJ; Drummond, M; Lau, HM; McDonald, C; Patel, MI; Raj, MD; Wang, AC; Woo, HH, 2011) |
| "Women with CHD also had a higher rate of cerebral ischemia than did men (27." | 1.36 | Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. ( Gerhat, D; Handisurya, A; Hudson, S; Kamyar, MR; Kautzky-Willer, A; Lemmens-Gruber, R; Luger, A; Stemer, G, 2010) |
| "Sex disparities in the diagnosis and treatment of chest pain or suspected angina have been demonstrated in multiple clinical settings." | 1.36 | Influence of sex on the out-of-hospital management of chest pain. ( Armstrong, K; Facenda, K; Mechem, CC; Meisel, ZF; Peacock, N; Pollack, CV; Shofer, FS, 2010) |
| "Aspirin use was associated with a lower risk of cardiovascular events (adjusted hazard ratio, 0." | 1.35 | Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study. ( Berger, JS; Brown, DL; Burke, GL; Kostis, JB; Langer, RD; Oberman, A; Wassertheil-Smoller, S; Wong, ND, 2009) |
| "We histologically assessed thrombus formation, cellular elements, localization of TRX and of oxidized low density lipoprotein (ox-LDL), intraplaque hemorrhage, and transition metal iron (Fe(2+), Fe(3+)) deposition in these specimens." | 1.35 | Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage. ( Asada, Y; Hatakeyama, K; Imamura, T; Kitamura, K; Nakamura, H; Nishihira, K; Ogawa, H; Sato, Y; Yamashita, A; Yodoi, J, 2008) |
| "Aspirin was given as 160 mg/day and clopidogrel as 300 mg loading dose followed by 75 mg/day." | 1.35 | Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris. ( Agewall, S; Berglund, M; Gordon, A; Saha, S; Sylvén, C, 2008) |
| "Patients with complex coronary stenoses had a significantly (P<0." | 1.32 | Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. ( Christiansen, M; Cole, D; Cosin-Sales, J; Holt, DW; Kaminski, P; Kaski, JC; Overgaard, MT; Oxvig, C, 2004) |
| "More than 90% of coronary aneurysms are of atherosclerotic origin." | 1.31 | Nonatherosclerotic aneurysm of the left circumflex coronary artery presenting with accelerated angina pectoris: response to medical management--a case report. ( Dogan, OM; Khan, IA; Sacchi, TJ; Vasavada, BC, 2000) |
| "Aspirin was used regularly by 37% of those with CVD and by 13% of those with risk factors only Adjusted odds of regular aspirin use were significantly greater for individuals with CVD than for those with one CVD risk factor (odds ratio [OR] = 4." | 1.31 | Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. ( Fagot-Campagna, A; Narayan, KM; Rolka, DB, 2001) |
| "Neurological examination revealed paresis of the left arm." | 1.31 | [Spontaneous intraspinal epidural hematoma secondary to use of platelet aggregation inhibitors]. ( Hoch, A; Kilisek, L; Spring, A; Weber, J, 2001) |
| "History of untreated hypertension prior to the initial stroke (RR = 1." | 1.30 | Stroke recurrence among 30 days survivors of ischemic stroke in a prospective community-based study. ( Baranska-Gieruszczak, M; Czlonkowska, A; Hier, DB; Lechowicz, W; Ryglewicz, D, 1997) |
| "Platelet thrombus formation and whole blood platelet aggregation were measured in 18 stable coronary patients on three separate occasions: at baseline when receiving no active medications, after 7 days of receiving oral verapamil SR (240 mg/d), and after 7 days of receiving a combination of oral verapamil SR and aspirin (325 mg/d)." | 1.29 | Oral verapamil inhibits platelet thrombus formation in humans. ( Hung, J; L-Lacoste, L; Lam, JY; Waters, D, 1994) |
| " A dose-response relation was found between level of anger and overall CHD risk (P for trend, ." | 1.29 | A prospective study of anger and coronary heart disease. The Normative Aging Study. ( Kawachi, I; Sparrow, D; Spiro, A; Vokonas, P; Weiss, ST, 1996) |
| "A 23-year-old male with bronchial asthma developed eosinophilia (eosinophils greater than 2,000/mm3) and was observed at our hospital." | 1.28 | [Acute myocardial injury and repeated angina pectoris-like attacks in a young patient with Churg-Strauss syndrome]. ( Arai, Y; Fukushima, N; Isokane, N; Miyamoto, Y; Sano, Y; Suzuki, N, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 92 (28.75) | 18.7374 |
| 1990's | 84 (26.25) | 18.2507 |
| 2000's | 102 (31.88) | 29.6817 |
| 2010's | 41 (12.81) | 24.3611 |
| 2020's | 1 (0.31) | 2.80 |
| Authors | Studies |
|---|---|
| Pavão, RB | 1 |
| Moreira, HT | 1 |
| Pintya, AO | 1 |
| Haddad, JL | 1 |
| Badran, AV | 1 |
| Lima-Filho, MO | 1 |
| Lago, IM | 1 |
| Chierice, JRA | 1 |
| Schmidt, A | 1 |
| Marin-Neto, JA | 1 |
| Kim, JB | 1 |
| Choi, BG | 1 |
| Rha, SW | 1 |
| Seo, HS | 1 |
| Choi, SY | 1 |
| Byun, JK | 1 |
| Na, JO | 1 |
| Choi, CU | 1 |
| Kim, EJ | 1 |
| Park, CG | 1 |
| Oh, DJ | 1 |
| Chang, AM | 1 |
| Litt, HI | 1 |
| Snyder, BS | 1 |
| Gatsonis, C | 1 |
| Greco, EM | 1 |
| Miller, CD | 1 |
| Singh, H | 1 |
| O'Conor, KJ | 1 |
| Hollander, JE | 1 |
| Fujimoto, W | 1 |
| Sawada, T | 1 |
| Toba, T | 1 |
| Takahashi, Y | 1 |
| Miyata, T | 1 |
| Oishi, S | 1 |
| Osue, T | 1 |
| Onishi, T | 1 |
| Takaya, T | 1 |
| Shimane, A | 1 |
| Taniguchi, Y | 1 |
| Kawai, H | 1 |
| Yasaka, Y | 1 |
| Grinshtein, YI | 1 |
| Kosinova, AA | 1 |
| Grinshtein, IY | 1 |
| Subbotina, TN | 1 |
| Savchenko, AA | 1 |
| Qureshi, R | 1 |
| Kao, L | 1 |
| Gupta, RP | 1 |
| Srivastava, P | 1 |
| Butler, J | 1 |
| Shroyer, AL | 1 |
| Lacey, M | 1 |
| Parikh, PB | 1 |
| Almas, A | 1 |
| Ghazni, MS | 1 |
| Hashmani, S | 1 |
| Mushtaq, Z | 1 |
| Barbarash, OL | 1 |
| Kashtalap, VV | 1 |
| Zykov, MV | 1 |
| Hryachkova, ON | 1 |
| Shibanova, IA | 1 |
| Deo, SV | 1 |
| Dunlay, SM | 1 |
| Shah, IK | 1 |
| Altarabsheh, SE | 1 |
| Erwin, PJ | 1 |
| Boilson, BA | 1 |
| Park, SJ | 1 |
| Joyce, LD | 1 |
| Loenko, VB | 1 |
| Sorokina, EA | 1 |
| Faĭl', IL | 1 |
| Smialovskiĭ, DV | 1 |
| Takeuchi, H | 1 |
| Phankingthongkum, R | 1 |
| Panchavinnin, P | 1 |
| Chinthammitr, Y | 1 |
| Tresukosol, D | 1 |
| Chotinaiwattarakul, C | 1 |
| Tungsubutra, W | 1 |
| Wongpraparut, N | 1 |
| Karevee, D | 1 |
| Sumalee, C | 1 |
| Puchin'ian, NF | 1 |
| Furman, NV | 1 |
| Dovgalevskiĭ, IaP | 1 |
| Martínez-Quintana, E | 1 |
| Medina-Gil, JM | 1 |
| Rodríguez-González, F | 1 |
| Garay-Sánchez, P | 1 |
| Limiñana, JM | 1 |
| Saavedra, P | 1 |
| Tugores, A | 1 |
| López Mínguez, JR | 1 |
| Nogales Asensio, JM | 1 |
| Doncel Vecino, LJ | 1 |
| Sandoval, J | 1 |
| Romany, S | 1 |
| Martínez Romero, P | 1 |
| Fernández Díaz, JA | 1 |
| Fernández Portales, J | 1 |
| González Fernández, R | 1 |
| Martínez Cáceres, G | 1 |
| Merchán Herrera, A | 1 |
| Alfonso Manterola, F | 1 |
| Jeger, RV | 1 |
| Pfisterer, ME | 1 |
| Sørensen, R | 1 |
| von Felten, S | 1 |
| Alber, H | 1 |
| Bonetti, PO | 1 |
| Eberli, F | 1 |
| Erne, P | 1 |
| Pedrazzini, G | 1 |
| Rickli, H | 1 |
| Galatius, S | 1 |
| Kaiser, CA | 2 |
| Wada, N | 1 |
| Okazaki, S | 1 |
| Kobayashi, S | 1 |
| Hashizume, K | 1 |
| Hori, J | 1 |
| Azumi, M | 1 |
| Kita, M | 1 |
| Iwata, T | 1 |
| Matsumoto, S | 1 |
| Kakizaki, H | 1 |
| Ichikawa, M | 1 |
| Takei, Y | 1 |
| Hamasaki, T | 1 |
| Kijima, Y | 1 |
| Wei, YQ | 1 |
| Wang, DG | 1 |
| Yang, H | 1 |
| Cao, H | 1 |
| Yildiz, BS | 1 |
| Ozkan, E | 1 |
| Esin, F | 1 |
| Alihanoglu, YI | 1 |
| Ozkan, H | 1 |
| Bilgin, M | 1 |
| Kilic, ID | 1 |
| Ergin, A | 1 |
| Kaftan, HA | 1 |
| Evrengul, H | 1 |
| Savino, PB | 1 |
| Sporer, KA | 1 |
| Barger, JA | 1 |
| Brown, JF | 1 |
| Gilbert, GH | 1 |
| Koenig, KL | 1 |
| Rudnick, EM | 1 |
| Salvucci, AA | 1 |
| Navarro, MA | 1 |
| Gosch, KL | 1 |
| Spertus, JA | 2 |
| Rumsfeld, JS | 1 |
| Ho, PM | 1 |
| Huang, J | 1 |
| Tang, X | 1 |
| Ye, F | 1 |
| He, J | 1 |
| Kong, X | 1 |
| Godfrey, A | 1 |
| Cajigas, HR | 1 |
| Gao, L | 1 |
| Li, YJ | 1 |
| Chen, KY | 1 |
| Cuisset, T | 2 |
| Hamilos, M | 2 |
| Sarma, J | 1 |
| Sarno, G | 1 |
| Wyffels, E | 1 |
| Vanderheyden, M | 1 |
| Barbato, E | 3 |
| Bartunek, J | 2 |
| De Bruyne, B | 2 |
| Wijns, W | 3 |
| Walter, T | 1 |
| Szabo, S | 1 |
| Kazmaier, S | 1 |
| Swoboda, S | 1 |
| Suselbeck, T | 1 |
| Brueckmann, M | 1 |
| Borggrefe, M | 2 |
| Beyer, ME | 1 |
| Hoffmeister, HM | 1 |
| Lim, SY | 1 |
| Kim, KS | 1 |
| Joo, SJ | 1 |
| Jeong, MH | 2 |
| Schneider, DJ | 1 |
| Sobel, BE | 1 |
| Weintraub, WS | 1 |
| Kolm, P | 1 |
| Maron, DJ | 1 |
| Zhang, Z | 1 |
| Jurkovitz, C | 1 |
| Zhang, W | 1 |
| Hartigan, PM | 2 |
| Lewis, C | 1 |
| Veledar, E | 1 |
| Bowen, J | 1 |
| Dunbar, SB | 1 |
| Deaton, C | 1 |
| Kaufman, S | 1 |
| O'Rourke, RA | 1 |
| Goeree, R | 1 |
| Barnett, PG | 1 |
| Teo, KK | 1 |
| Boden, WE | 1 |
| Mancini, GB | 2 |
| Ramsdale, DR | 1 |
| Rao, A | 1 |
| Asghar, O | 1 |
| Ramsdale, KA | 1 |
| McKay, E | 1 |
| Frere, C | 1 |
| Quilici, J | 1 |
| Uhry, S | 1 |
| Morange, PE | 1 |
| Mouret, JP | 1 |
| Gaborit, B | 1 |
| Bali, L | 1 |
| Moro, PJ | 1 |
| Lambert, M | 1 |
| Bonnet, JL | 1 |
| Mrdovic, I | 1 |
| Perunicic, J | 1 |
| Asanin, M | 1 |
| Matic, M | 1 |
| Vasiljevic, Z | 1 |
| Ostojic, M | 1 |
| Hokimoto, S | 1 |
| Matsui, K | 1 |
| Oshima, S | 1 |
| Noda, K | 1 |
| Kaikita, K | 1 |
| Sumida, H | 1 |
| Sugiyama, S | 1 |
| Ogawa, H | 3 |
| Ranjith, MP | 1 |
| Divya, R | 1 |
| Mehta, VK | 1 |
| Krishnan, MG | 1 |
| KamalRaj, R | 1 |
| Kavishwar, A | 1 |
| Stellos, K | 1 |
| Bigalke, B | 1 |
| Stakos, D | 1 |
| Henkelmann, N | 1 |
| Gawaz, M | 2 |
| Berger, JS | 1 |
| Brown, DL | 1 |
| Burke, GL | 1 |
| Oberman, A | 1 |
| Kostis, JB | 1 |
| Langer, RD | 1 |
| Wong, ND | 1 |
| Wassertheil-Smoller, S | 1 |
| Meisel, ZF | 1 |
| Armstrong, K | 1 |
| Mechem, CC | 1 |
| Shofer, FS | 1 |
| Peacock, N | 1 |
| Facenda, K | 1 |
| Pollack, CV | 1 |
| Xue, F | 1 |
| Yang, XJ | 1 |
| Cheng, XJ | 1 |
| Hui, J | 1 |
| Jiang, TB | 1 |
| Chen, T | 1 |
| Liu, ZH | 1 |
| Song, JP | 1 |
| Jiang, WP | 1 |
| Muller, O | 1 |
| Ulrichts, H | 1 |
| Mangiacapra, F | 2 |
| Holz, JB | 1 |
| Ntalianis, A | 1 |
| Trana, C | 1 |
| Dierickx, K | 1 |
| Vercruysse, K | 1 |
| Kim, SS | 1 |
| Kim, HK | 1 |
| Kim, MC | 1 |
| Cho, KH | 1 |
| Lee, MG | 1 |
| Ko, JS | 1 |
| Park, KH | 1 |
| Sim, DS | 1 |
| Yoon, NS | 1 |
| Yoon, HJ | 1 |
| Park, HW | 1 |
| Kim, JH | 1 |
| Hong, YJ | 1 |
| Ahn, YK | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
| Dvir, D | 1 |
| Battler, A | 1 |
| Batyraliev, TA | 1 |
| Fettser, DV | 1 |
| Samko, AN | 1 |
| Sidorenko, BA | 1 |
| Menown, IB | 1 |
| Kautzky-Willer, A | 1 |
| Kamyar, MR | 1 |
| Gerhat, D | 1 |
| Handisurya, A | 1 |
| Stemer, G | 1 |
| Hudson, S | 1 |
| Luger, A | 1 |
| Lemmens-Gruber, R | 1 |
| Peace, AJ | 1 |
| Raj, MD | 1 |
| McDonald, C | 1 |
| Brooks, AJ | 1 |
| Drummond, M | 1 |
| Lau, HM | 1 |
| Patel, MI | 1 |
| Bariol, SV | 1 |
| Wang, AC | 1 |
| Woo, HH | 1 |
| Eskandarian, R | 1 |
| Darabian, M | 1 |
| Heshmatnia, J | 1 |
| Ghorbani, R | 1 |
| Elgin, U | 1 |
| Sen, E | 1 |
| Teke, MY | 1 |
| Tirhis, H | 1 |
| Ozturk, F | 1 |
| Soejima, H | 1 |
| Kishikawa, H | 1 |
| Linares Vicente, JA | 1 |
| Pérez, JO | 1 |
| Lacasa, RC | 1 |
| Plummer, W | 1 |
| Macchi, L | 1 |
| Christiaens, L | 1 |
| Brabant, S | 1 |
| Sorel, N | 1 |
| Allal, J | 1 |
| Mauco, G | 1 |
| Brizard, A | 1 |
| Almagor, M | 1 |
| Keren, A | 1 |
| Banai, S | 1 |
| Toutouzas, K | 1 |
| Di Mario, C | 1 |
| Falotico, R | 1 |
| Takagi, T | 1 |
| Stankovic, G | 1 |
| Albiero, R | 1 |
| Corvaja, N | 1 |
| Colombo, A | 2 |
| Fujita, M | 1 |
| Mizuno, K | 1 |
| Ho, M | 1 |
| Tsukahara, R | 1 |
| Miyamoto, A | 1 |
| Miki, O | 1 |
| Ishii, K | 1 |
| Miwa, K | 2 |
| Borja, J | 1 |
| Pérez, I | 1 |
| De la Cruz, G | 1 |
| Shakib, S | 1 |
| George, A | 1 |
| Wright, J | 1 |
| Warren, E | 1 |
| Reeves, J | 1 |
| Bibby, J | 1 |
| Harrison, S | 1 |
| Dowswell, G | 1 |
| Russell, I | 1 |
| Russell, D | 1 |
| Oganov, RG | 1 |
| Lepakhin, VK | 1 |
| Fitilev, SB | 1 |
| Levin, AM | 1 |
| Titarova, YY | 1 |
| Sytchev, EN | 1 |
| Kopp, CW | 1 |
| Steiner, S | 1 |
| Priglinger, U | 1 |
| Christ, G | 1 |
| Probst, P | 1 |
| Maurer, G | 1 |
| Minar, E | 1 |
| Huber, K | 1 |
| MATTHEWS, JC | 1 |
| Neumann, FJ | 2 |
| Kastrati, A | 2 |
| Pogatsa-Murray, G | 1 |
| Mehilli, J | 2 |
| Bollwein, H | 1 |
| Bestehorn, HP | 1 |
| Schmitt, C | 1 |
| Seyfarth, M | 1 |
| Dirschinger, J | 2 |
| Schömig, A | 2 |
| Górecki, A | 1 |
| Chamiec, T | 1 |
| Bednarz, B | 1 |
| Maciejewski, P | 1 |
| Łukaszewicz, R | 1 |
| Ceremuzyński, L | 1 |
| Van der Planken, MG | 2 |
| Claeys, MJ | 2 |
| Vertessen, FJ | 1 |
| Dilling, D | 2 |
| Bosmans, JM | 2 |
| Berneman, ZN | 1 |
| Michiels, JJ | 2 |
| Vrints, C | 1 |
| Jaster, M | 1 |
| Fuster, V | 3 |
| Rosenthal, P | 1 |
| Pauschinger, M | 1 |
| Tran, QV | 1 |
| Janssen, D | 1 |
| Hinkelbein, W | 1 |
| Schwimmbeck, P | 1 |
| Schultheiss, HP | 1 |
| Rauch, U | 1 |
| Fleming, T | 1 |
| Nissen, SE | 1 |
| Borer, JS | 1 |
| Armstrong, PW | 1 |
| Cosin-Sales, J | 1 |
| Christiansen, M | 1 |
| Kaminski, P | 1 |
| Oxvig, C | 1 |
| Overgaard, MT | 1 |
| Cole, D | 1 |
| Holt, DW | 1 |
| Kaski, JC | 1 |
| Nagai, R | 1 |
| Bradshaw, PJ | 1 |
| Jamrozik, K | 1 |
| Gilfillan, I | 1 |
| Thompson, PL | 1 |
| Genest, M | 1 |
| Pochmalicki, G | 1 |
| Blazing, MA | 1 |
| de Lemos, JA | 1 |
| White, HD | 1 |
| Fox, KA | 1 |
| Verheugt, FW | 1 |
| Ardissino, D | 1 |
| DiBattiste, PM | 1 |
| Palmisano, J | 1 |
| Bilheimer, DW | 1 |
| Snapinn, SM | 1 |
| Ramsey, KE | 1 |
| Gardner, LH | 1 |
| Hasselblad, V | 1 |
| Pfeffer, MA | 1 |
| Lewis, EF | 1 |
| Braunwald, E | 1 |
| Califf, RM | 3 |
| Akbulut, M | 1 |
| Ozbay, Y | 1 |
| Karaca, I | 1 |
| Ilkay, E | 1 |
| Gundogdu, O | 1 |
| Arslan, N | 1 |
| Bolognese, L | 1 |
| Ducci, K | 1 |
| Angioli, P | 1 |
| Falsini, G | 1 |
| Liistro, F | 1 |
| Baldassarre, S | 1 |
| Burali, A | 1 |
| Tran, H | 1 |
| Anand, SS | 1 |
| Grossmann, R | 1 |
| Sokolova, O | 1 |
| Schnurr, A | 1 |
| Bonz, A | 1 |
| Porsche, C | 1 |
| Obergfell, A | 1 |
| Lengenfelder, B | 1 |
| Walter, U | 1 |
| Eigenthaler, M | 1 |
| Ferrari, E | 1 |
| Benhamou, M | 1 |
| Cerboni, P | 1 |
| Marcel, B | 1 |
| Karcz, M | 1 |
| Ruzyłło, W | 1 |
| Kounis, NG | 2 |
| Kouni, SN | 1 |
| Koutsojannis, CM | 1 |
| Dibra, A | 1 |
| Braun, S | 1 |
| Hadamitzky, M | 1 |
| Baum, H | 1 |
| Schühlen, H | 1 |
| Labarthe, B | 1 |
| Théroux, P | 2 |
| Angioï, M | 1 |
| Ghitescu, M | 1 |
| Sun, JC | 1 |
| Crowther, MA | 1 |
| Warkentin, TE | 1 |
| Lamy, A | 1 |
| Teoh, KH | 1 |
| Rzeczuch, K | 1 |
| Szajn, G | 1 |
| Jankowska, E | 1 |
| Kaczmarek, A | 1 |
| Derkacz, A | 1 |
| Porada, A | 1 |
| Telichowski, A | 1 |
| Banasiak, W | 1 |
| Ponikowski, P | 1 |
| Crowe, B | 1 |
| Abbas, S | 1 |
| Meany, B | 1 |
| de Haan, J | 1 |
| Cahill, MR | 1 |
| Kaneda, H | 1 |
| Suzuki, J | 1 |
| Hosokawa, G | 1 |
| Tanaka, S | 1 |
| Hiroe, Y | 1 |
| Saito, S | 1 |
| Hughes, P | 1 |
| Hasenkam, JM | 1 |
| Severinsen, IK | 1 |
| Steinbrüchel, DA | 1 |
| Boztosun, B | 1 |
| Gunes, Y | 1 |
| Kirma, C | 1 |
| Barutcu, I | 1 |
| van Werkum, JW | 1 |
| Heestermans, AA | 1 |
| Jaarsma, W | 1 |
| Hautvast, RW | 1 |
| de Boer, MJ | 1 |
| ten Berg, JM | 1 |
| Sheng, JQ | 1 |
| Li, SR | 1 |
| Yang, XY | 1 |
| Zhang, YH | 1 |
| Su, H | 1 |
| Yu, DL | 1 |
| Yan, W | 1 |
| Geng, HG | 1 |
| Serebruany, VL | 1 |
| Midei, MG | 1 |
| Meilman, H | 1 |
| Malinin, AI | 1 |
| Lowry, DR | 1 |
| Smith, C | 1 |
| Damås, JK | 1 |
| Otterdal, K | 1 |
| Øie, E | 1 |
| Sandberg, WJ | 1 |
| Yndestad, A | 1 |
| Waehre, T | 1 |
| Scholz, H | 1 |
| Endresen, K | 1 |
| Olofsson, PS | 1 |
| Halvorsen, B | 1 |
| Gullestad, L | 1 |
| Frøland, SS | 1 |
| Hansson, GK | 1 |
| Aukrust, P | 1 |
| Prasan, AM | 1 |
| Bhagwandeen, R | 1 |
| Solanki, VJ | 1 |
| Freedman, SB | 1 |
| Brieger, D | 1 |
| Ioannidis, TI | 1 |
| Mazarakis, A | 1 |
| Notaras, SP | 1 |
| Karpeta, MZ | 1 |
| Tsintoni, AC | 1 |
| Kounis, GN | 1 |
| Rallis, DG | 1 |
| Krüth, P | 1 |
| Heer, T | 1 |
| Senges, J | 1 |
| Zeymer, U | 1 |
| Pamukcu, B | 1 |
| Oflaz, H | 1 |
| Onur, I | 1 |
| Oncul, A | 1 |
| Ozcan, M | 1 |
| Umman, B | 1 |
| Mercanoglu, F | 1 |
| Meric, M | 1 |
| Nisanci, Y | 1 |
| Saha, S | 1 |
| Berglund, M | 1 |
| Sylvén, C | 1 |
| Gordon, A | 1 |
| Agewall, S | 1 |
| Karlsson, G | 1 |
| Rehman, J | 1 |
| Kalaria, V | 1 |
| Breall, JA | 1 |
| Majdoub, MA | 1 |
| Sauguet, A | 1 |
| Tchetche, D | 1 |
| Ducrocq, G | 1 |
| Benamer, H | 1 |
| Himbert, D | 1 |
| Aubry, P | 1 |
| Feldman, LJ | 1 |
| Steg, PG | 1 |
| Juliard, JM | 1 |
| Schneider, CA | 1 |
| Erdmann, E | 1 |
| Inami, N | 1 |
| Nomura, S | 1 |
| Kimura, Y | 1 |
| Yamada, K | 1 |
| Nakamori, H | 1 |
| Takahashi, N | 1 |
| Fukuhara, S | 1 |
| Iwasaka, T | 1 |
| Kishida, H | 1 |
| Smedema, JP | 1 |
| Berlion, AE | 1 |
| Morkel, H | 1 |
| Friedewald, VE | 1 |
| King, SB | 2 |
| Pepine, CJ | 2 |
| Vetrovec, GW | 1 |
| Roberts, WC | 1 |
| Naimushin, A | 1 |
| Livneh, A | 1 |
| Nielsen, AA | 1 |
| Veien, KT | 1 |
| Jørgensen, LG | 1 |
| Buck, TC | 1 |
| Brandslund, I | 1 |
| Christensen, C | 1 |
| Nishihira, K | 1 |
| Yamashita, A | 1 |
| Imamura, T | 1 |
| Hatakeyama, K | 1 |
| Sato, Y | 1 |
| Nakamura, H | 1 |
| Yodoi, J | 1 |
| Kitamura, K | 1 |
| Asada, Y | 1 |
| Matsumoto, M | 1 |
| Suehiro, K | 1 |
| Kubo, Y | 1 |
| Onoue, G | 1 |
| Komatsubara, I | 1 |
| Seito, T | 1 |
| Morimoto, N | 1 |
| Shiraishi, K | 1 |
| Kasai, S | 1 |
| Hagioka, S | 1 |
| Naito, H | 1 |
| Nagae, M | 1 |
| Marshall, AJ | 1 |
| Epstein, SE | 1 |
| Palmeri, ST | 1 |
| Caruzzo, C | 1 |
| Sechi, A | 1 |
| Monti, C | 1 |
| Campagna, G | 1 |
| Spinnler, MT | 1 |
| Sanborn, TA | 1 |
| Faxon, DP | 2 |
| Kellett, MA | 2 |
| Ryan, TJ | 1 |
| Thornton, MA | 1 |
| Gruentzig, AR | 1 |
| Hollman, J | 1 |
| Douglas, JS | 1 |
| Hayashi, H | 1 |
| Kisamori, K | 1 |
| Kaneko, M | 1 |
| Masumura, Y | 1 |
| Kamikawa, T | 1 |
| Kobayashi, A | 1 |
| Suzuki, Y | 1 |
| Yamazaki, N | 1 |
| Yamaguchi, T | 1 |
| Harada, Y | 1 |
| Eichner, ER | 1 |
| Rivey, MP | 1 |
| Alexander, MR | 1 |
| Taylor, JW | 1 |
| Willerson, JT | 3 |
| Campbell, WB | 1 |
| Winniford, MD | 1 |
| Schmitz, J | 1 |
| Apprill, P | 1 |
| Firth, BG | 1 |
| Ashton, J | 1 |
| Smitherman, T | 1 |
| Bush, L | 1 |
| Buja, LM | 1 |
| Lewy, RI | 1 |
| Born, GV | 2 |
| Elwood, PC | 1 |
| Fisher, LD | 1 |
| Kennedy, JW | 1 |
| Gazes, PC | 1 |
| De Vita, C | 1 |
| Passamani, ER | 1 |
| Lands, WE | 1 |
| Pitt, BW | 1 |
| Culp, BR | 1 |
| Handin, RI | 2 |
| Alexander, RW | 1 |
| Robertson, RM | 1 |
| Robertson, D | 1 |
| Roberts, LJ | 1 |
| Maas, RL | 1 |
| FitzGerald, GA | 3 |
| Friesinger, GC | 1 |
| Oates, JA | 1 |
| van de Loo, J | 1 |
| Frishman, WH | 3 |
| Almazov, VA | 1 |
| Vashkinel', VK | 1 |
| Safronnikov, LV | 1 |
| Lapotnikov, VA | 1 |
| Petrov, MN | 1 |
| Zdichynec, B | 1 |
| Kambara, H | 1 |
| Kawai, C | 1 |
| Delanoe, G | 1 |
| Green, LH | 1 |
| Seroppian, E | 1 |
| Weiss, HJ | 1 |
| Mehta, J | 1 |
| Mehta, P | 1 |
| Conti, CR | 1 |
| Meier, B | 2 |
| Grover, GJ | 1 |
| Schumacher, WA | 1 |
| Ogletree, ML | 1 |
| Magnani, B | 1 |
| Semprini, F | 1 |
| Montalescot, G | 2 |
| Hargreaves, MR | 1 |
| Firoozan, S | 1 |
| Forfar, JC | 1 |
| Modesti, PA | 3 |
| Colella, A | 1 |
| Cecioni, I | 1 |
| Costoli, A | 1 |
| Biagini, D | 1 |
| Migliorini, A | 1 |
| Neri Serneri, GG | 5 |
| Zavecz, JH | 1 |
| Bueno, O | 1 |
| Dittel, M | 2 |
| Haushofer, A | 2 |
| Spiel, R | 1 |
| Halbmayer, WM | 2 |
| Prachar, H | 2 |
| Fischer, M | 2 |
| Mlczoch, J | 2 |
| McMurray, J | 1 |
| Rankin, A | 1 |
| Bonnier, JJ | 1 |
| Post, D | 1 |
| Shetty, K | 1 |
| Lasserre, B | 1 |
| Périat, M | 1 |
| Maclouf, J | 1 |
| Drobinski, G | 1 |
| Salloum, J | 1 |
| Grosgogeat, Y | 1 |
| Thomas, D | 1 |
| Winther, K | 1 |
| Husted, SE | 1 |
| Vissinger, H | 1 |
| Gensini, GF | 4 |
| Poggesi, L | 2 |
| Rostagno, C | 2 |
| Boddi, M | 2 |
| Gori, AM | 1 |
| Martini, F | 1 |
| Ieri, A | 2 |
| Margheri, M | 2 |
| Wallén, NH | 2 |
| Held, C | 2 |
| Rehnqvist, N | 2 |
| Hjemdahl, P | 2 |
| L-Lacoste, L | 1 |
| Lam, JY | 1 |
| Hung, J | 1 |
| Waters, D | 1 |
| Goodnight, SH | 1 |
| Coull, BM | 1 |
| McAnulty, JH | 1 |
| Taylor, LM | 1 |
| Ilia, R | 1 |
| Kolanski, D | 1 |
| Setaro, J | 1 |
| Brennan, J | 1 |
| Cabin, H | 1 |
| Cleman, M | 1 |
| Remetz, M | 1 |
| Szczeklik, A | 1 |
| Musial, J | 1 |
| Undas, A | 1 |
| Swadzba, J | 1 |
| Gora, PF | 1 |
| Piwowarska, W | 1 |
| Duplaga, M | 1 |
| Williams, S | 1 |
| Fatah, K | 2 |
| Ivert, T | 2 |
| Blombäck, M | 2 |
| Reininger, A | 1 |
| Chirkov, YY | 1 |
| Horowitz, JD | 1 |
| Beving, H | 1 |
| Albåge, A | 1 |
| Kawachi, I | 1 |
| Sparrow, D | 1 |
| Spiro, A | 1 |
| Vokonas, P | 1 |
| Weiss, ST | 1 |
| Doughty, RN | 1 |
| Sharpe, N | 1 |
| Jackson, G | 1 |
| Folland, ED | 1 |
| Parisi, AF | 1 |
| Herlitz, J | 1 |
| Albertsson, P | 1 |
| Brandrup-Wognsen, G | 1 |
| Emanuelsson, H | 2 |
| Haglid, M | 1 |
| Hartford, M | 1 |
| Hjalmarson, A | 1 |
| Karlson, BW | 1 |
| Karlsson, T | 1 |
| Sandén, W | 1 |
| Ryglewicz, D | 1 |
| Baranska-Gieruszczak, M | 1 |
| Czlonkowska, A | 1 |
| Lechowicz, W | 1 |
| Hier, DB | 1 |
| Wenger, NK | 1 |
| van de Loo, A | 1 |
| Nauck, M | 1 |
| Noory, E | 1 |
| Just, H | 1 |
| Wollschläger, H | 1 |
| Eccles, M | 1 |
| Freemantle, N | 1 |
| Mason, J | 1 |
| Oemrawsingh, PV | 1 |
| Tuinenburg, JC | 1 |
| Schalij, MJ | 1 |
| Jukema, JW | 1 |
| Reiber, JH | 1 |
| Bruschke, AV | 1 |
| McNeely, W | 1 |
| Goa, KL | 1 |
| Asirvatham, S | 1 |
| Sebastian, C | 1 |
| Thadani, U | 1 |
| Berglund, U | 1 |
| Lindahl, T | 1 |
| Serruys, PW | 1 |
| van Hout, B | 1 |
| Bonnier, H | 1 |
| Legrand, V | 1 |
| Garcia, E | 1 |
| Macaya, C | 1 |
| Sousa, E | 1 |
| van der Giessen, W | 1 |
| Seabra-Gomes, R | 1 |
| Kiemeneij, F | 1 |
| Ruygrok, P | 1 |
| Ormiston, J | 1 |
| Fajadet, J | 2 |
| Haude, M | 2 |
| Klugmann, S | 1 |
| Morel, MA | 1 |
| Alvarez, JM | 1 |
| Harper, RW | 1 |
| Peverill, RE | 1 |
| Nyberg, G | 1 |
| Caidahl, K | 1 |
| Kharitonova, N | 1 |
| Petersson, AS | 1 |
| Chiamvimonvat, V | 1 |
| Sternberg, L | 1 |
| Bing, M | 1 |
| Abel, RL | 1 |
| Pendergrass, P | 1 |
| Malone, M | 1 |
| Sabharwal, K | 1 |
| McCauley, C | 1 |
| Petticrew, M | 1 |
| Turner-Boutle, M | 1 |
| Sheldon, T | 1 |
| McTaggart, D | 1 |
| Ikonomidis, I | 1 |
| Andreotti, F | 2 |
| Economou, E | 1 |
| Stefanadis, C | 2 |
| Toutouzas, P | 2 |
| Nihoyannopoulos, P | 1 |
| de Rosis, F | 1 |
| Grasso, F | 1 |
| Berry, DC | 1 |
| Jenkins, NP | 1 |
| Meyer, MI | 1 |
| Kuhn, M | 1 |
| Bühler, H | 1 |
| Bertschinger, P | 1 |
| Bouvy, ML | 1 |
| Heerdink, ER | 1 |
| Klungel, OH | 1 |
| de Boer, A | 1 |
| Stuurman-Bieze, AG | 1 |
| Leufkens, HG | 1 |
| Tanasescu, S | 1 |
| Lévesque, H | 1 |
| Thuillez, C | 1 |
| Karila-Cohen, D | 1 |
| Gabriel Steg, P | 1 |
| Foussas, S | 1 |
| Alexopoulos, D | 1 |
| Olympios, C | 1 |
| Voudris, V | 1 |
| Hatzimiltiadis, S | 1 |
| Sionis, D | 1 |
| Vavouranakis, E | 1 |
| Vrahatis, A | 1 |
| Fakiolas, C | 1 |
| Pissimisis, E | 1 |
| Stefanidis, A | 1 |
| Zairis, M | 1 |
| Pavlides, G | 1 |
| Vitakis, S | 1 |
| Louridas, G | 1 |
| Cokkinos, D | 1 |
| Suzuki, S | 1 |
| Matsuo, T | 1 |
| Kobayashi, H | 1 |
| Matsuo, M | 1 |
| Shimamo, C | 1 |
| Koide, M | 1 |
| Sakamoto, S | 1 |
| Le Quan Sang, KH | 1 |
| Le Feuvre, C | 1 |
| Brunet, A | 1 |
| Pham, TD | 1 |
| Metzger, JP | 1 |
| Vacheron, A | 1 |
| Devynck, MA | 1 |
| Bochkareva, EV | 1 |
| Kucheriavaia, NG | 1 |
| Kokurina, EV | 1 |
| Metelitsa, VI | 1 |
| Kondrat'ev, VV | 1 |
| Gurfinkel, EP | 2 |
| Santopinto, J | 1 |
| Bozovich, GE | 1 |
| Quispe, A | 1 |
| Strinna, A | 1 |
| Mautner, B | 2 |
| Khan, IA | 1 |
| Dogan, OM | 1 |
| Vasavada, BC | 1 |
| Sacchi, TJ | 1 |
| Delahaye, JP | 1 |
| Guize, L | 1 |
| Ducimetière, P | 1 |
| Consoli, SM | 1 |
| Kolsky, H | 1 |
| Raynaud, P | 1 |
| Walch, JM | 1 |
| Paul-Dauphin, A | 1 |
| Duprat-Lomon, I | 1 |
| Altman, R | 1 |
| Scazziota, A | 1 |
| Heguilen, R | 1 |
| Marco, J | 1 |
| Ariëns, RA | 1 |
| Bossi, IM | 1 |
| Marco, I | 1 |
| Bernies, M | 1 |
| Romano, SM | 1 |
| Donatelli, F | 1 |
| Brambilla, GM | 1 |
| Somalvico, F | 1 |
| Mari, D | 1 |
| Gregorini, L | 1 |
| Peter, K | 1 |
| Nordt, T | 1 |
| Bode, C | 1 |
| Fischetti, D | 1 |
| Sciahbasi, A | 1 |
| Leone, AM | 1 |
| Niccoli, G | 1 |
| Schiavoni, G | 1 |
| Trani, C | 1 |
| Mazzari, MA | 1 |
| Hézard, N | 1 |
| Metz, D | 1 |
| Garnotel, R | 1 |
| Droullé, C | 1 |
| Potron, G | 1 |
| Nguyen, P | 1 |
| Rolka, DB | 1 |
| Fagot-Campagna, A | 1 |
| Narayan, KM | 1 |
| Naber, CK | 1 |
| Rahman, YA | 1 |
| Erbel, R | 1 |
| Baumgart, D | 1 |
| Diener, HC | 2 |
| Darius, H | 2 |
| Bertrand-Hardy, JM | 2 |
| Humphreys, M | 2 |
| McCarty, D | 1 |
| Walsh, SJ | 1 |
| Adgey, AA | 1 |
| Olson, J | 1 |
| Huntington, J | 1 |
| Weber, J | 1 |
| Hoch, A | 1 |
| Kilisek, L | 1 |
| Spring, A | 1 |
| Fihn, SD | 1 |
| Williams, SV | 1 |
| Daley, J | 1 |
| Gibbons, RJ | 1 |
| Gheeraert, PJ | 1 |
| Henriques, JP | 1 |
| De Buyzere, ML | 1 |
| De Pauw, M | 1 |
| Taeymans, Y | 1 |
| Zijlstra, F | 1 |
| Denktas, AE | 1 |
| Bayes-Genis, A | 1 |
| Schwartz, RS | 1 |
| Bittl, JA | 1 |
| Chaitman, BR | 1 |
| Feit, F | 1 |
| Kimball, W | 1 |
| Topol, EJ | 3 |
| Poerner, TC | 1 |
| Kralev, S | 1 |
| Voelker, W | 1 |
| Sueselbeck, T | 1 |
| Latsch, A | 1 |
| Pfleger, S | 1 |
| Schumacher, B | 1 |
| Haase, KK | 1 |
| Knottenbelt, C | 1 |
| Brennan, PJ | 1 |
| Meade, TW | 1 |
| Vertessen, F | 1 |
| Vrints, CJ | 1 |
| Aviles, RJ | 1 |
| Askari, AT | 1 |
| Lindahl, B | 1 |
| Wallentin, L | 1 |
| Jia, G | 1 |
| Ohman, EM | 1 |
| Mahaffey, KW | 1 |
| Newby, LK | 1 |
| Simoons, ML | 1 |
| Berger, P | 1 |
| Lauer, MS | 1 |
| Saleh, N | 1 |
| Hansson, LO | 1 |
| Kohut, M | 1 |
| Nilsson, T | 1 |
| Tornvall, P | 1 |
| Arrigo, F | 1 |
| Coglitore, S | 1 |
| Virga, T | 1 |
| Giannetto, M | 1 |
| Bramanti, B | 1 |
| Melluso, C | 1 |
| Consolo, F | 1 |
| Atanasov, K | 1 |
| Yovkova, T | 1 |
| Tzvetkova, T | 1 |
| Davis, JW | 1 |
| Lewis, HD | 3 |
| Phillips, PE | 1 |
| Schwegler, RA | 1 |
| Yue, KT | 1 |
| Hassanein, KR | 1 |
| Gantmacher, ML | 1 |
| Verstraete, M | 2 |
| Evangelisti, GB | 1 |
| Faggioli, F | 1 |
| Garagnani, A | 1 |
| Lama, G | 1 |
| Linos, A | 1 |
| Worthington, JW | 1 |
| O'Fallon, W | 1 |
| Whisnant, JP | 1 |
| Kurland, LT | 1 |
| Stornello, M | 1 |
| Aloisi, B | 1 |
| Stuto, A | 1 |
| Vinci, E | 1 |
| Bozzanca, L | 1 |
| Christodoulou, J | 1 |
| Weksler, B | 1 |
| Smithen, C | 1 |
| Killip, T | 1 |
| Scheidt, S | 1 |
| Guyton, JR | 1 |
| Wu, KK | 1 |
| Hoak, JC | 1 |
| Willard, JE | 1 |
| Lange, RA | 1 |
| Hillis, LD | 1 |
| Trenkwalder, P | 1 |
| Lydtin, H | 1 |
| Kübler, W | 1 |
| Hoberg, E | 1 |
| Weber, R | 1 |
| Juul-Möller, S | 1 |
| Edvardsson, N | 1 |
| Jahnmatz, B | 1 |
| Rosén, A | 1 |
| Sørensen, S | 1 |
| Omblus, R | 1 |
| Klein, W | 2 |
| Eber, B | 2 |
| Fruhwald, F | 1 |
| Akhmedzhanov, MIu | 1 |
| Ezhova, LV | 1 |
| Arkhangel'skiĭ, VV | 1 |
| Roux, S | 1 |
| Christeller, S | 1 |
| Lüdin, E | 1 |
| Kerins, DM | 1 |
| Ferlito, S | 1 |
| Suzuki, N | 1 |
| Arai, Y | 1 |
| Miyamoto, Y | 1 |
| Isokane, N | 1 |
| Fukushima, N | 1 |
| Sano, Y | 1 |
| Kirichenko, AA | 1 |
| Dan'shina, OE | 1 |
| Repinskaia, NP | 1 |
| Ioseliani, DG | 1 |
| Rishko, NV | 1 |
| Ridker, PM | 3 |
| Manson, JE | 3 |
| Buring, JE | 3 |
| Goldhaber, SZ | 2 |
| Hennekens, CH | 3 |
| Carpenter, AL | 1 |
| Caravalho, J | 1 |
| Trotta, F | 1 |
| Casolo, GC | 1 |
| Bini, M | 1 |
| Bleifeld, W | 1 |
| Morrison, DA | 1 |
| Boudoulas, H | 1 |
| Gaziano, JM | 2 |
| Atakhanova, LZ | 1 |
| Mazurov, AV | 1 |
| Katsenovich, ER | 1 |
| Karpov, IuA | 1 |
| Kostko, SZ | 1 |
| Repin, VS | 1 |
| Ruda, MIa | 1 |
| Williams, DO | 1 |
| Roberts, R | 1 |
| Joelson, JM | 1 |
| Ellis, SG | 1 |
| Kleiman, NS | 1 |
| Rutherford, JD | 1 |
| Cohen, M | 1 |
| Adams, PC | 1 |
| Hawkins, L | 1 |
| Bach, M | 1 |
| Grobbee, DE | 1 |
| Stampfer, MJ | 1 |
| Taylor, JO | 1 |
| Bichan, NA | 1 |
| Gol'dberg, GA | 1 |
| Kristensen, SD | 1 |
| Bath, PM | 1 |
| Martin, JF | 1 |
| Abbate, R | 2 |
| Castellani, S | 1 |
| Bonechi, F | 1 |
| Carnovali, M | 1 |
| Dabizzi, RP | 1 |
| Dagianti, A | 1 |
| Arata, L | 1 |
| Vejar, M | 2 |
| Fragasso, G | 1 |
| Hackett, D | 2 |
| Lipkin, DP | 1 |
| Maseri, A | 2 |
| Ciabattoni, G | 1 |
| Patrono, C | 2 |
| Schreiber, TL | 2 |
| Macina, G | 2 |
| Bunnell, P | 2 |
| Tenney, RD | 1 |
| McNulty, A | 2 |
| Kikel, M | 2 |
| Miller, DH | 2 |
| Zola, BE | 1 |
| Tracy, R | 1 |
| Stump, D | 1 |
| Brunelli, C | 1 |
| Spallarossa, P | 1 |
| Ianetti, M | 1 |
| Galassi, AR | 1 |
| Lipkin, D | 1 |
| Caponnetto, S | 1 |
| von Dohlen, TW | 1 |
| Rogers, WB | 1 |
| Frank, MJ | 1 |
| Gratsianskiĭ, NA | 1 |
| Resnekov, L | 1 |
| Chediak, J | 1 |
| Hirsh, J | 2 |
| Silberberg, JS | 1 |
| McGregor, M | 1 |
| Charvat, J | 1 |
| Kuruvilla, T | 1 |
| Fluch, N | 1 |
| Dusleag, J | 1 |
| Weinrauch, V | 1 |
| Rotman, B | 1 |
| Gasser, R | 1 |
| Kronberger-Schaffer, E | 1 |
| Davì, G | 1 |
| Catalano, I | 1 |
| Spatola, A | 1 |
| Alaimo, P | 1 |
| Notarbartolo, A | 1 |
| Cerbone, AM | 1 |
| Strano, A | 1 |
| Devereux, RB | 1 |
| Tenney, R | 1 |
| Cowley, M | 1 |
| Zola, B | 1 |
| Khimenko, PL | 1 |
| Hugenholtz, PG | 2 |
| Cohen, LS | 1 |
| Luchi, RJ | 1 |
| Scott, SM | 1 |
| Deupree, RH | 1 |
| Leeman, DE | 1 |
| McCabe, CH | 1 |
| Lorell, BH | 1 |
| McKay, RG | 1 |
| Varricchione, T | 1 |
| Baim, DS | 1 |
| Seth, A | 1 |
| Perry, RA | 1 |
| Shiu, MF | 1 |
| van den Berg, EK | 1 |
| Schmitz, JM | 1 |
| Benedict, CR | 1 |
| Malloy, CR | 1 |
| Dehmer, GJ | 1 |
| Hamad, JF | 1 |
| Miller, KP | 1 |
| Gershlick, AH | 1 |
| Lyons, JP | 1 |
| Wright, JE | 1 |
| Sturridge, MF | 1 |
| Layton, CA | 1 |
| Balcon, R | 1 |
| Ouimet, H | 1 |
| McCans, J | 1 |
| Latour, JG | 1 |
| Joly, P | 1 |
| Lévy, G | 1 |
| Pelletier, E | 1 |
| Juneau, M | 1 |
| Stasiak, J | 1 |
| deGuise, P | 1 |
| Ahmad, RA | 1 |
| Watson, RD | 1 |
| Petch, MC | 1 |
| Punzengruber, C | 1 |
| Silberbauer, K | 1 |
| Sinzinger, H | 1 |
| Panetta, A | 1 |
| Pinto, S | 1 |
| Favilla, S | 1 |
| Prisco, D | 1 |
| Sakai, K | 1 |
| Yamazaki, T | 1 |
| Nakamura, Y | 1 |
| Sugimoto, T | 1 |
| Shimizu, Y | 1 |
| Tanaka, T | 1 |
| Takayama, Y | 1 |
| Hayashi, T | 1 |
| Ito, Y | 1 |
| Abe, M | 1 |
| Matsuda, M | 1 |
| Ida, T | 1 |
| Sakakibara, T | 1 |
| Obunai, Y | 1 |
| Rehr, RB | 1 |
| DiSciascio, G | 1 |
| Cowley, MJ | 1 |
| Cairns, JA | 3 |
| Hansen, JF | 1 |
| Hansen, BF | 1 |
| Lecompte, T | 1 |
| Samama, M | 1 |
| Orlov, VA | 1 |
| Iakunin, GA | 2 |
| Khishtovani, AI | 2 |
| Myers, MG | 2 |
| Singer, J | 2 |
| Bates, ER | 1 |
| Mickelson, JK | 1 |
| Dmitriev, AA | 1 |
| Kormer, AIa | 1 |
| Brown, BG | 1 |
| Cukingnan, RA | 1 |
| DeRouen, T | 1 |
| Goede, LV | 1 |
| Wong, M | 1 |
| Fee, HJ | 1 |
| Roth, JA | 1 |
| Carey, JS | 1 |
| Sherry, S | 1 |
| Ogawa, K | 1 |
| Ito, T | 1 |
| Gent, M | 1 |
| Finnie, KJ | 1 |
| Froggatt, GM | 1 |
| Holder, DA | 1 |
| Jablonsky, G | 1 |
| Kostuk, WJ | 1 |
| Melendez, LJ | 1 |
| Courillon-Mallet, A | 1 |
| Wautier, JL | 1 |
| Martin, JL | 1 |
| Fisher, CA | 1 |
| Untereker, WJ | 1 |
| Laskey, WK | 1 |
| Hirshfeld, JW | 1 |
| Harken, AH | 1 |
| Addonizio, VP | 1 |
| Kingdon, HS | 1 |
| Weser, C | 1 |
| Scheidler, K | 1 |
| Loew, D | 1 |
| Wellmer, HK | 1 |
| Baer, U | 1 |
| Merguet, H | 1 |
| Rumpf, P | 1 |
| Petersen, H | 1 |
| Bromig, G | 1 |
| Persch, WF | 1 |
| Marx, FJ | 1 |
| von Bary, SM | 1 |
| Harkavy, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Tailored Use of Tirofiban in Patients With Non-ST-elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention[NCT03114995] | Phase 4 | 140 participants (Actual) | Interventional | 2012-02-01 | Completed | ||
| CSP #424 - Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation[NCT00007657] | Phase 3 | 3,260 participants (Anticipated) | Interventional | 1998-12-31 | Completed | ||
| Quality of Life and Achievement of Target of Treatment After Optimized Medical Treatment, Physical Training and Smoking Cessation With or Without Percutaneous Coronary Intervention in Patients With Stable Angina Pectoris.[NCT00825604] | Phase 2 | 0 participants (Actual) | Interventional | 2009-01-31 | Withdrawn (stopped due to Because of poor inclusion difficulties to find patient) | ||
| Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status[NCT04475094] | 75 participants (Anticipated) | Observational | 2019-12-23 | Recruiting | |||
| Arterial Imaging of Inflammation and Resolution After Endovascular Surgery[NCT03590769] | Phase 1 | 9 participants (Actual) | Interventional | 2017-06-01 | Completed | ||
| Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of the Glycoprotein IIb/IIIa Inhibition With Abciximab in Patients With ACS Undergoing Coronary Stenting After Pretreatment With a High Loading Dose of Clopidogrel (ISAR-REACT-2)[NCT00133003] | Phase 4 | 2,022 participants (Actual) | Interventional | 2003-03-31 | Completed | ||
| Acute Angioplasty (Primary PCI) Versus Traditional Early Invasive Treatment of Patients Presenting With NSTEMI (The Second Danish Non-ST-Elevation MI Trial - DaNSTEMI-2)[NCT00493584] | 14 participants (Actual) | Interventional | 2008-03-31 | Terminated (stopped due to Due to insufficient patient inclusion the study has been stopped prematurely.) | |||
| Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Abciximab And Bivalirudin in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Interventions (ISAR-REACT-4)[NCT00373451] | Phase 4 | 1,721 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| Maintenance of an Antiaggregation by Acetylsalicylic Acid, Less or Equal to 250mg While a Extracorporeal Lithotripsy (ECL) Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study[NCT03437057] | 300 participants (Anticipated) | Interventional | 2018-01-08 | Recruiting | |||
| Effect of Low Molecular Weight Heparin vs Unfractionated Heparin on Bleeding After Cardiac Surgery[NCT00420667] | 43 participants (Actual) | Interventional | 2004-11-30 | Completed | |||
| Phase I/IIa Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2[NCT03333590] | Phase 1/Phase 2 | 2 participants (Actual) | Interventional | 2017-11-06 | Active, not recruiting | ||
| Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures[NCT05292846] | Phase 4 | 200 participants (Anticipated) | Interventional | 2022-01-20 | Recruiting | ||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation in High Risk Primary Prevention (Patients With Metabolic Syndrome)[NCT00272311] | Phase 4 | 70 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation & Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease)[NCT00272337] | Phase 4 | 37 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [NCT00000500] | Phase 3 | 0 participants | Interventional | 1981-09-30 | Completed | ||
| Effect of Information on Placebo in the Informed Consent on the Trial Outcomes and Participant Blinding[NCT04182295] | 89 participants (Actual) | Interventional | 2019-10-07 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
An area under the curve of serial levels of Troponin I and creatine kinase-MB isoenzyme during 36 hours (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours
| Intervention | Hours*ng/ml (Median) | |
|---|---|---|
| Troponin I | creatine kinase-MB isoenzyme | |
| Control C1 (High Platelet Reactivity - no Tirofiban) | 38.0 | 92.7 |
| Control C2 (Low Platelet Reactivity - no Tirofiban) | 121.4 | 185.6 |
| Group A (High Platelet Reactivity - Tirofiban) | 197.2 | 252.5 |
"Percentage of participants with periprocedural myonecrosis under the criteria described below.~When the cardiac biomarkers before the procedure were within the 99th percentile upper reference limit (URL), more than a 5-fold elevation in the URL within 12 hours after percutaneous coronary intervention (PCI) was defined as periprocedural myonecrosis. If the cardiac biomarker level was already above the 99th percentile URL before the procedure and the trend was stationary or decreasing, a ≥20% increase compared to the previous level was considered periprocedural myonecrosis. If the trend was still increasing, the levels at the post-6 hour and 12-hour were compared to determine periprocedural myonecrosis." (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Troponin I | creatine kinase-MB isoenzyme | |
| Control C1 (High Platelet Reactivity - no Tirofiban) | 15 | 10 |
| Control C2 (Low Platelet Reactivity - no Tirofiban) | 26 | 25 |
| Group A (High Platelet Reactivity - Tirofiban) | 16 | 11 |
Percentage of fibers expressing GALGT2 in each biopsy sample. (NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1)
| Intervention | Percentage of Positive Fibers (Number) |
|---|---|
| Cohort 1 (Minimal Efficacious Dose) | 1.95 |
| Cohort 2 | 1.72 |
(NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1)
| Intervention | ng/mg total protein (Number) |
|---|---|
| Cohort 1 (Minimal Efficacious Dose) | 12 |
| Cohort 2 | 14.6 |
(NCT03333590)
Timeframe: 2 years
| Intervention | events (Number) |
|---|---|
| Cohort 1 (Minimal Efficacious Dose) | 0 |
| Cohort 2 | 0 |
(NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1) and Day 180 for both cohorts
| Intervention | meters (Number) | |
|---|---|---|
| Day 90 (Cohort 2) /Day 120 (Cohort 1) | Day 180 | |
| Cohort 1 (Minimal Efficacious Dose) | 320 | 324 |
| Cohort 2 (Minimal Efficacious Dose) | 405 | 416 |
The NSAA provides a score between 0 and 34 where higher numbers represent greater muscle function. (NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1) and both Cohorts at Day 180, Months 12, 18 and 24
| Intervention | score on a scale (Number) | ||||
|---|---|---|---|---|---|
| Day 90/Day 120 | Day 180 | Month 12 | Month 18 | Month 24 | |
| Cohort 1 (Minimal Efficacious Dose) | 16 | 14 | 10 | 6 | 2 |
| Cohort 2 | 21 | 23 | 23 | 23 | 23 |
(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1) and both Cohorts at Day 180, Months 12, 18 and 24
| Intervention | kg (Number) | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 90/Day 120-Right Knee Extension | Day 90/Day 120-Right Knee Flexion | Day 90/Day 120- Left Knee Extension | Day 90/Day 120-Left Knee Flexion | Day 180-Right Knee Extension | Day 180-Right Knee Flexion | Day 180-Left Knee Extension | Day 180-Left Knee Flexion | Month 12-Right Knee Extension | Month 12-Right Knee Flexion | Month 12-Left Knee Extension | Month 12-Left Knee Flexion | Month 18-Right Knee Extension | Month 18-Right Knee Flexion | Month 18-Left Knee Extension | Month 18-Left Knee Flexion | Month 24-Right Knee Extension | Month 24-Right Knee Flexion | Month 24-Left Knee Extension | Month 24-Left Knee Flexion | |
| Cohort 1 (Minimal Efficacious Dose) | 7.42 | 6.06 | 8.78 | 6.12 | 7.13 | 6.1 | 8.66 | 6.69 | 7.49 | 5.67 | 7.5 | 5.32 | 4.55 | 6.11 | 4.96 | 6.26 | 5.06 | 4.41 | 6.93 | 4.17 |
| Cohort 2 | 7.04 | 8.12 | 5.9 | 8.4 | 9.73 | 4.24 | 8.19 | 5.25 | 9.85 | 5.85 | 8.02 | 5.12 | 7.67 | 6.89 | 7.34 | 6.08 | 9.81 | 5.04 | 5.21 | 4.87 |
(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1); both Cohorts at Day 180, Months 12, 18 and Cohort 2 at Month 24
| Intervention | seconds (Number) | |||
|---|---|---|---|---|
| Day 90/Day 120 | Day 180 | Month 12 | Month 18 | |
| Cohort 1 (Minimal Efficacious Dose) | 98.2 | 110.9 | 144.5 | 167.8 |
(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1); both Cohorts at Day 180, Months 12, 18 and Cohort 2 at Month 24
| Intervention | seconds (Number) | ||||
|---|---|---|---|---|---|
| Day 90/Day 120 | Day 180 | Month 12 | Month 18 | Month 24 | |
| Cohort 2 | 56.1 | 44.9 | 44.7 | 65.6 | 48.4 |
Changes in Heme oxygenase (HO-1) a downstream target of nitric oxide (NO) formation. (NCT00272311)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| Arm 1 of 5 Randomized Treatment Arms | 27.6 |
| Arm 2 of 5 Randomized Treatment Arms | 27.0 |
| Arm 3 of 5 Randomized Treatment Arms | 31.4 |
| Arm 4 of 5 Randomized Treatment Arms | 25.7 |
| Arm 5 of 5 Randomized Treatment Arms | 28.3 |
Heme oxygenase a downstream target of nitric oxide formation (NCT00272337)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| 1 of 5 Randomized Treatment Arms | 10.0 |
| 2 of 5 Randomized Treatment Arms | 11.2 |
| 3 of 5 Randomized Treatment Arms | 10.0 |
| 4 of 5 Randomized Treatment Arms | 11.0 |
| 5 of 5 Randomized Treatment Arms | 9.6 |
61 reviews available for aspirin and Angor Pectoris
| Article | Year |
|---|---|
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
Topics: Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occl | 2013 |
Chest Pain of Suspected Cardiac Origin: Current Evidence-based Recommendations for Prehospital Care.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Angina Pectoris; Aspirin; California; Clinical Prot | 2015 |
Clinical Therapeutic Effects of Aspirin in Combination with Fufang Danshen Diwan, a Traditional Chinese Medicine Formula, on Coronary Heart Disease: A Systematic Review and Meta-Analysis.
Topics: Angina Pectoris; Aspirin; Cardiotonic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Di | 2016 |
Conventional and novel drug therapeutics to relief myocardial ischemia.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors | 2010 |
Contemporary management of coronary heart disease.
Topics: Acute Coronary Syndrome; Administration, Oral; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti | 2010 |
Sirolimus-eluting stents: a review of experimental and clinical findings.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Animals; Aspirin; Clopidogrel; Coronary Angiography | 2002 |
Choosing a drug from within a class.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Aspirin; Australia; Decision Making; Drug Costs; | 2003 |
[Recent progress in diagnosis of and therapy for angina pectoris].
Topics: Angina Pectoris; Aspirin; Biomarkers; Catheterization; Coronary Artery Bypass; Creatine Kinase; Crea | 2004 |
[Acute coronary syndromes without ST segment elevation].
Topics: Acute Disease; Adrenergic beta-Antagonists; Analgesics, Opioid; Angina Pectoris; Angiotensin-Convert | 2004 |
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopido | 2004 |
[Standard pharmacological therapy associated with percutaneous coronary interventions in patients with stable angina].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Fibrinolytic Agents; Hepar | 2004 |
[Stable angina pectoris, angina pectoris of effort, stable angina pectoris of effort].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon; Aspirin; Circadian Rhythm; Diagn | 2007 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; C | 1981 |
Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Animals; Antic | 1984 |
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosi | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
[Interference in platelet-fibrinogen system for prevention and therapy of myocardial infarct].
Topics: Angina Pectoris; Anticoagulants; Aspirin; Fibrinolysis; Humans; Myocardial Infarction; Recurrence | 1982 |
Antiplatelet therapy in coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disor | 1982 |
[Blood thinning in heart patients].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Aspirin; Atrial Fibrillation; Clini | 1995 |
Pharmacologic therapy of angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug | 1995 |
Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris.
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inh | 1994 |
Prescribing for angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Humans; Myocardial | 1994 |
Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction).
Topics: Administration, Oral; Angina Pectoris; Antithrombins; Aspirin; Humans; Injections, Intravenous; Male | 1994 |
Antiplatelet therapy--Part I.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cardiovascular Diseases; Coronary Artery Bypass; Coronar | 1993 |
[Anticoagulation in cardiology].
Topics: 4-Hydroxycoumarins; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial | 1995 |
Optimal treatment of angina in older patients.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angina Pectoris; Angioplasty, Balloon, Laser-Assiste | 1996 |
Coronary heart disease: an older woman's major health risk.
Topics: Aged; Angina Pectoris; Aspirin; Cholesterol; Coronary Disease; Estrogen Replacement Therapy; Female; | 1997 |
North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.
Topics: Angina Pectoris; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Consumer Product Safet | 1998 |
Triflusal.
Topics: Adult; Angina Pectoris; Animals; Aspirin; Carotid Stenosis; Humans; In Vitro Techniques; Middle Aged | 1998 |
Choosing the most appropriate treatment for stable angina. Safety considerations.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspiri | 1998 |
Coronary artery disease in women.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin-Converting En | 1998 |
Cardiology 7. Stable angina pectoris: treatment and referral options.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti-Inflammator | 1999 |
[Pharmacology of aspirin].
Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Br | 2000 |
[Aspirin and prevention of cardiovascular risk].
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Ste | 2000 |
[Therapeutic inhibition of platelets in a acute coronary syndrome and in coronary intervention: mechanisms and clinical results].
Topics: Abciximab; Acute Disease; Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; | 2000 |
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal | 2000 |
Current management issues in angina.
Topics: Angina Pectoris; Aspirin; Coronary Angiography; Diagnosis, Differential; Exercise Test; Humans; Hypo | 2001 |
New approaches to the pharmacological treatment of angina.
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inh | 2001 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
The use of aspirin in ischemic heart disease.
Topics: Angina Pectoris; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Myocardial Revascularizat | 1992 |
[Therapeutic possibilities, respective implications in silent ischemia].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Coronary Artery Byp | 1992 |
[Is it necessary to treat silent myocardial ischemia?].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Coronary Artery Bypass; Co | 1992 |
Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis.
Topics: Angina Pectoris; Aspirin; Chemotherapy, Adjuvant; Coronary Thrombosis; Female; Humans; Male; Meta-An | 1992 |
The current role of platelet-active drugs in ischaemic heart disease.
Topics: Angina Pectoris; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhi | 1991 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery | 1991 |
Unstable angina: pathophysiology and drug therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Calcium Cha | 1990 |
Unstable angina and thrombolysis.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Coronary Thrombosis; Heparin; Humans; Thrombolytic Thera | 1990 |
Pathophysiology and management of unstable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Aspirin; Electrocardiography; Hepari | 1989 |
Antithrombotic agents in coronary artery disease.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Platelet | 1989 |
Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategies.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Circulation; Humans; | 1989 |
Calcium antagonists for angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticoagulants; Aspirin; Calcium Channel Blockers; Hum | 1988 |
Management of unstable angina soon after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Anticoagulants | 1988 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a | 1986 |
An aspirin a day for unstable angina?
Topics: Angina Pectoris; Aspirin; Humans; Risk Factors | 1988 |
Thrombosis in unstable angina: angiographic aspects.
Topics: Angina Pectoris; Angina, Unstable; Angiography; Arteries; Aspirin; Coronary Circulation; Coronary Di | 1987 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Arte | 1987 |
[Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology].
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Calcium Channel Blockers; Coronary Angiography; Coronary | 1987 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
[Analogs of prostaglandin-related substances and inhibitors of their synthesis and metabolism. Clinical application: cardiovascular diseases].
Topics: Angina Pectoris; Aspirin; Coronary Disease; Epoprostenol; Humans; Hypertension; Methacrylates; Myoca | 1985 |
Cardiac manifestations due to hypersensitivity.
Topics: Adams-Stokes Syndrome; Anaphylaxis; Angina Pectoris; Antigen-Antibody Complex; Arrhythmias, Cardiac; | 1970 |
79 trials available for aspirin and Angor Pectoris
| Article | Year |
|---|---|
Aspirin plus verapamil relieves angina and perfusion abnormalities in patients with coronary microvascular dysfunction and Chagas disease: a pilot non-randomized study.
Topics: Angina Pectoris; Aspirin; Chagas Disease; Female; Humans; Male; Middle Aged; Perfusion; Quality of L | 2021 |
Impact of Coronary Computed Tomography Angiography Findings on Initiation of Cardioprotective Medications.
Topics: Acute Coronary Syndrome; Adult; Angina Pectoris; Aspirin; Clinical Decision-Making; Computed Tomogra | 2017 |
[Potential utility of optic aggregometry for identification of patients with coronary heart disease resistant to acetylsalicylic acid].
Topics: Acute Disease; Adult; Angina Pectoris; Aspirin; Coronary Disease; Drug Resistance; Female; Humans; M | 2013 |
A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; C | 2014 |
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.
Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-El | 2014 |
[Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin].
Topics: Aged; Angina Pectoris; Aspirin; Blood Circulation; Cell Adhesion; Drug Tolerance; Drugs, Chinese Her | 2008 |
Effect of clopidogrel on adhesion molecules, hemostasis, and fibrinolysis in coronary heart disease.
Topics: Aged; Angina Pectoris; Aspirin; Cell Adhesion Molecules; Chronic Disease; Clopidogrel; Double-Blind | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C | 2008 |
Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogre | 2009 |
[Implantation of the paclitaxel-eluting stent Apollo in patients with stable angina pectoris: long-term angiographic and clinical results].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronar | 2010 |
Sarpogrelate treatment reduces restenosis after coronary stenting.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cell Division; Coronary Angiography; | 2003 |
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Topics: Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; C | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; | 2003 |
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans | 2004 |
The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; C | 2004 |
Variable extent of clopidogrel responsiveness in patients after coronary stenting.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Corona | 2004 |
Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug.
Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; | 2005 |
Impact of heparin neutralization by protamine on restenosis after coronary stent implantation.
Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Reste | 2005 |
Postoperative treatment with low molecular weight heparin after right heart assist for coronary artery bypass grafting.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Antifibrinolytic Agents; Aspirin; C | 2005 |
[Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
Topics: Adenomatous Polyposis Coli; Adolescent; Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non- | 2006 |
Serial angiography in patients with acute coronary syndromes: effect of antithrombotic therapy on angiographic lesion severity.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Steno | 2006 |
Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR).
Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Disease; Death; Drug Resistance; Female | 2007 |
Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Animals; Antic | 1984 |
Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coumarins; Follow-Up Studies; Humans; M | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials a | 1980 |
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Arteries; Aspirin; Clinical Trials as Topic; Coron | 1981 |
Exercise-induced angina provoked by aspirin administration in patients with variant angina.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Coronary Angiography; Electrocardio | 1981 |
Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Angina Pectoris; Aspirin; Cardiac Pacing, | 1994 |
The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Hu | 1994 |
Antiplatelet therapy--Part I.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cardiovascular Diseases; Coronary Artery Bypass; Coronar | 1993 |
Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?
Topics: Adult; Aged; Analysis of Variance; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Diseas | 1996 |
Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs AC
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Calcium Chann | 1997 |
Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Female; Humans; Male; Middle | 1998 |
Enhanced onset of platelet inhibition with a loading dose of ticlopidine in ASA-treated stable coronary patients.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Female; Humans; Male; Middle Aged; Platelet Aggregation I | 1998 |
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspi | 1998 |
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; | 1999 |
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; | 1999 |
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; | 1999 |
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; | 1999 |
Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting.
Topics: Acenocoumarol; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coron | 2000 |
Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Topics: Aged; alpha-2-Antiplasmin; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Antithro | 2000 |
[Acetylsalicylic acid effects on pain sensitivity to myocardial ischemia and skin sensitivity in patients with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Aspirin; Chest Pain; Double-Blind Method; Electric Stimulation; Electr | 2000 |
Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin.
Topics: Acute Disease; Angina Pectoris; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Fema | 2000 |
Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes.
Topics: Analysis of Variance; Angina Pectoris; Aspirin; Cross-Over Studies; Female; Humans; Lysine; Male; Mi | 2000 |
Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris.
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antithrombin III; Aspirin; Athere | 2000 |
Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
Topics: Angina Pectoris; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Longitudinal Studies; My | 2001 |
[Does early high dosage dipyridamole in prevention of secondary stroke induce cardiac events?].
Topics: Administration, Oral; Angina Pectoris; Aspirin; Cause of Death; Cerebral Infarction; Delayed-Action | 2001 |
Antithrombotic treatment and the incidence of angina pectoris.
Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Cohort Studies; Coronary Disease; Double-Blind Metho | 2002 |
Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention.
Topics: Abciximab; Adenosine Diphosphate; Aged; Aged, 80 and over; Angina Pectoris; Antibodies, Monoclonal; | 2002 |
Effect of aspirin on exercise-induced angina.
Topics: Adult; Angina Pectoris; Aspirin; Blood Cell Count; Blood Platelets; Clinical Trials as Topic; Double | 1978 |
Aspirin therapy in angina pectoris: effects on platelet aggregation, exercise tolerance, and electrocardiographic manifestations of ischemia.
Topics: Adult; Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Disease; Female; Heart Function | 1976 |
Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.
Topics: Aged; Angina Pectoris; Aspirin; Double-Blind Method; Female; Hemorrhage; Humans; Male; Myocardial In | 1992 |
The current role of platelet-active drugs in ischaemic heart disease.
Topics: Angina Pectoris; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhi | 1991 |
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Coronary Artery Disease; Co | 1991 |
Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
Topics: Administration, Oral; Aged; Analysis of Variance; Angina Pectoris; Angina, Unstable; Aspirin; Double | 1990 |
Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; beta Carotene; Cardiovascular Diseases; Ca | 1991 |
Ticlopidine in unstable angina. A more expensive aspirin?
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Cost-Benefit Analysis; Cycloox | 1990 |
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.
Topics: Aged; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Cardiac Catheterization; Coronary Ang | 1990 |
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Artery | 1990 |
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Double-Blind Method; Follow-Up Studies; Hu | 1990 |
Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina.
Topics: Adolescent; Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coron | 1990 |
Unstable angina or non-Q wave infarction despite long-term aspirin: response to thrombolytic therapy with implications on mechanisms.
Topics: Aged; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Biomechanical Phenomena; Cerebral Hem | 1990 |
Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Diltiazem; Drug Therapy, Combination; Electrocardiograph | 1990 |
Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategies.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Circulation; Humans; | 1989 |
Comparative study of heparin and antiplatelets in treatment of preinfarction angina.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Dipyridamole; Dru | 1989 |
[Do thrombocyte aggregation inhibitors modify silent episodes of unstable angina pectoris in combined anti-angina therapy?].
Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Coronary Circulation; Diltiazem; Drug Therapy, Com | 1989 |
Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Coronary Angiography; Drug Therapy, Combination; Electro | 1989 |
Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Clinical Trial | 1987 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a | 1986 |
Long term clinical outcome of coronary surgery and assessment of the benefit obtained with postoperative aspirin and dipyridamole.
Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up | 1988 |
Aspirin, heparin, or both to treat acute unstable angina.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Double-Blind Me | 1988 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Arte | 1987 |
Aspirin to prevent myocardial infarction and death.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Female; Humans; Male; Myocardi | 1986 |
Effectiveness of anticoagulants.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood | 1986 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1986 |
Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Di | 1985 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Ther | 1985 |
Unstable angina: status of aspirin and other forms of therapy.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Double | 1985 |
[Therapeutic prospects and prostaglandins in vascular pathology].
Topics: Angina Pectoris; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteritis; Aspirin; | 1985 |
[Prevention of postoperative thrombo-embolism with acetylsalicyclic acid (author's transl)].
Topics: Age Factors; Angina Pectoris; Aspirin; Body Weight; Diabetes Complications; Female; Follow-Up Studie | 1974 |
189 other studies available for aspirin and Angor Pectoris
| Article | Year |
|---|---|
Recommendations on the Clinical Use of Compound Danshen Dripping Pills.
Topics: Angina Pectoris; Aspirin; Camphanes; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diabetic Neph | 2017 |
Clinical characteristics and outcomes of patients with coronary artery spasm who initially presented with acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Dise | 2018 |
Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy.
Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Administratio | 2018 |
The Prognostic Value of Combinations of Genetic Polymorphisms in the ITGB3, ITGA2, and CYP2C19*2 Genes in Predicting Cardiovascular Outcomes After Coronary Bypass Grafting.
Topics: Aged; Alleles; Angina Pectoris; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Byp | 2018 |
Coronary artery fistula with associated Takotsubo cardiomyopathy: a case report.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Aspirin; Cardiac Catheterization; Catecholamines; Chest Pai | 2018 |
Impact of Depressive Disorder on Access and Quality of Care in Veterans With Prevalent Cardiovascular Disease.
Topics: Age Distribution; Aged; Angina Pectoris; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; | 2018 |
Aspirin in Primary Prevention of Myocardial Infarction/Angina and Stroke in Hypertensive Patients.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Cardiovascular Diseases; Cross-Sectional S | 2018 |
[The Pathways to Increase the Efficacy of Drug Therapy in Patients with Ischemic Heart Disease after Coronary Artery Bypass Grafting].
Topics: Aged; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus, | 2019 |
[Assessment of clinical and antiaggregation efficacy of generic clopidogrel 'Egithromb' in roentgenosurgical practice].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronar | 2013 |
64-MDCT can depict the thrombi expanded from the left lower pulmonary vein to the left atrium in the patient with angina pectoris.
Topics: Aged; Angina Pectoris; Aspirin; Coronary Thrombosis; Diagnosis, Differential; Echocardiography; Hear | 2013 |
Aspirin resistance in Thai patients with chronic stable angina.
Topics: Aged; Angina Pectoris; Asian People; Aspirin; Chronic Disease; Drug Resistance; Female; Humans; Male | 2013 |
Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants.
Topics: Aged; Alleles; Angina Pectoris; Aryldialkylphosphatase; Aspirin; Clopidogrel; Cohort Studies; Corona | 2014 |
[Perioperative complications of transurethral resection of bladder tumor in patients receiving antithrombotic therapy].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Cystectomy; Female; Fibrinolytic Agents; Hemorrha | 2014 |
Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents.
Topics: Activation, Metabolic; Aged; Alleles; Angina Pectoris; Angioscopy; Aspirin; Clopidogrel; Coronary An | 2015 |
Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome.
Topics: Activation, Metabolic; Acute Coronary Syndrome; Aged; Alleles; Angina Pectoris; Aspirin; Clopidogrel | 2015 |
Does high serum uric acid level cause aspirin resistance?
Topics: Aged; Angina Pectoris; Aspirin; Biomarkers; Blood Cell Count; Blood Glucose; C-Reactive Protein; Cor | 2016 |
Chronic Kidney Disease and Health Status Outcomes Following Acute Myocardial Infarction.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Case-Control Studies; Coho | 2016 |
A 55-Year-Old Woman With Pulmonary Hypertension, Worsening Dyspnea, and Chest Pain.
Topics: Angina Pectoris; Aspirin; Clopidogrel; Compartment Syndromes; Coronary Vessels; Diagnosis, Different | 2014 |
Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Confidence Intervals; Elective Surgical Procedures; Fem | 2008 |
Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance.
Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Resista | 2008 |
Lack of early augmentation of platelet reactivity after coronary intervention in patients treated with bivalirudin.
Topics: Adenosine Diphosphate; Angina Pectoris; Anticoagulants; Aspirin; Cardiac Catheterization; Clopidogre | 2009 |
Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coro | 2008 |
Transient left ventricular apical ballooning complicated by a mural thrombus and outflow tract obstruction in a patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Angina Pectoris; Anticoagulants; Aspirin; Che | 2008 |
Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Female; Follow-Up Studies; Gastric M | 2009 |
Significance of platelet volume indices and platelet count in ischaemic heart disease.
Topics: Acute Coronary Syndrome; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cell Size; Female; | 2009 |
Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication.
Topics: Acute Coronary Syndrome; Angina Pectoris; Aspirin; Biomarkers; Blood Platelets; Clopidogrel; Coronar | 2010 |
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clini | 2009 |
Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study.
Topics: Aged; Angina Pectoris; Aspirin; Cardiovascular Diseases; Death, Sudden, Cardiac; Dose-Response Relat | 2009 |
Influence of sex on the out-of-hospital management of chest pain.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Aspirin; Chest Pain; Emergency Medical Services; Fem | 2010 |
Subacute coronary stent thrombosis in a patient with angina treated with double antiplatelet drugs for six days.
Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; D | 2009 |
Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Platelets; Clopido | 2010 |
Long-term clinical course of patients with isolated myocardial bridge.
Topics: Aged; Angina Pectoris; Aspirin; Coronary Angiography; Coronary Vasospasm; Female; Follow-Up Studies; | 2010 |
Understanding angina. When chest pain strikes, it's essential to know what action to take.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Chest Pain; Combined Modality Therapy; Cor | 2010 |
Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Aspirin; Blood Gluco | 2010 |
[Current status of medical therapy of chronic stable angina pectoris in mainland of China: the second survey].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angiotensin Receptor A | 2010 |
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Glucose; Blood Platelets; Clopidogrel; Diab | 2011 |
Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications.
Topics: Aged; Angina Pectoris; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Blood Transfusion; Humans; Isc | 2011 |
Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors.
Topics: Aged; Angina Pectoris; Aspirin; Drug Resistance; Female; Humans; Male; Middle Aged; Risk Factors | 2012 |
Microtrauma-induced recurrent hyphema and secondary glaucoma associated with chronic acetylsalicylic acid use.
Topics: Administration, Oral; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Diagnosis, Different | 2012 |
[Aspirin].
Topics: Angina Pectoris; Aspirin; Coronary Disease; Female; Humans; Male; Myocardial Infarction | 2011 |
Long-term successful percutaneous coronary intervention in factor VII deficiency.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Diabetes M | 2012 |
The power of statistics.
Topics: Angina Pectoris; Aspirin; Confidence Intervals; Drug Prescriptions; Health Facility Size; Humans; Ph | 2002 |
How to keep chest pain from cramping your style. If you are one of the millions of Americans for whom chest pain is part of daily life, here are some ABCs for getting it under control.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Aspirin; Chest Pain; Diet; Exercise; Fema | 2002 |
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate.
Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Aspirin; Blood Platelets; Case-Control Studies; Corona | 2002 |
Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; C-Reacti | 2003 |
Clopidogrel and percutaneous coronary interventions.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Administration Schedule; | 2003 |
Effectiveness of multifaceted implementation of guidelines in primary care.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Asthma; Bronchodilator Agents; Drug Utilizati | 2003 |
[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Angiotens | 2003 |
[CHEST PSEUDOANGINA DUE TO COSTAL CHONDRODYNIA. TIETZE'S SYNDROME].
Topics: Angina Pectoris; Aspirin; Cartilage; Diagnosis, Differential; Humans; Ribs; Thorax; Tietze's Syndrom | 1963 |
Is preinfarction angina associated with better outcome after myocardial infarction?
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-I | 2003 |
Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
Topics: Abciximab; Adenosine Diphosphate; Aged; Angina Pectoris; Antibodies, Monoclonal; Aspirin; Bleeding T | 2003 |
Catheter based intracoronary brachytherapy leads to increased platelet activation.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Platelets; Brachythe | 2004 |
Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD.
Topics: Acetanilides; Angina Pectoris; Aspirin; Clinical Trials as Topic; Delayed-Action Preparations; Drug | 2004 |
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Biomarkers; Blood Proteins; C-Reactive Protein; Coro | 2004 |
Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; | 2004 |
Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes.
Topics: Abciximab; Acute Disease; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclo | 2004 |
Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.
Topics: Aged; Angina Pectoris; Aspirin; Coronary Artery Disease; Female; Fibrinolytic Agents; Graft Occlusio | 2005 |
Myocardial infarction after aspirin treatment, and Kounis syndrome.
Topics: Angina Pectoris; Aspirin; Coronary Vasospasm; Fibrinolytic Agents; Humans; Mast Cells; Myocardial In | 2005 |
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Mono | 2005 |
Should aspirin be discontinued before coronary artery bypass surgery?
Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox | 2005 |
Should aspirin be discontinued before coronary artery bypass surgery?
Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox | 2005 |
Should aspirin be discontinued before coronary artery bypass surgery?
Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox | 2005 |
Should aspirin be discontinued before coronary artery bypass surgery?
Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox | 2005 |
Borderline coronary lesions may lead to serious coronary events--long-term outcome in 65 conservatively treated patients.
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Coronary | 2005 |
Detection of aspirin resistance by PFA-100: prevalence and aspirin compliance in patients with chronic stable angina.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Case-Control Studies; Female; Humans; Male | 2005 |
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combinatio | 2006 |
[Thrombosis of a coronary stent after discontinuing treatment with clopidogrel].
Topics: Adult; Aged; Angina Pectoris; Aspirin; Clopidogrel; Female; Humans; Male; Myocardial Infarction; Pla | 2006 |
Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.
Topics: Angina Pectoris; Aspirin; Chronic Disease; Coronary Stenosis; Drug Therapy, Combination; Humans; Mal | 2006 |
Softening the blow.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Car | 2006 |
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Arteries; Aspirin; beta-Thromboglobulin; Blood Pla | 2006 |
Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Animals; Anti-Inflammatory Agents, Non-Steroidal | 2007 |
[Acute myocardial infarction after discontinuing aspirin two years after implantation of a drug-eluting coronary stent].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Contraindications; Coronary Angiography; C | 2007 |
Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
Topics: Angina Pectoris; Aspirin; Chronic Disease; Clopidogrel; Humans; Platelet Aggregation; Platelet Aggre | 2008 |
Increased incidence of stent thrombosis in patients with cocaine use.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cocaine-Related Disorders; Co | 2007 |
[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronar | 2007 |
[Stable angina pectoris can be treated successfully by drugs alone--pro].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cal | 2007 |
Evaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columns.
Topics: Aged; Angina Pectoris; Aspirin; Blood Platelets; Case-Control Studies; Collagen; Female; Hemorheolog | 2007 |
Myocardial infarcts in a patient with a single right sided coronary ostium and interarterial course of the circumflex artery: the role of multi-modality imaging.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticholesteremic Agents; Antihypertensive Agents; Asp | 2009 |
The editor's roundtable: chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Calcium Chann | 2007 |
[Aspirin and endoscopy].
Topics: Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colonoscopy; Drug Administr | 2008 |
[Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations].
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Aspirin; | 2008 |
Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage.
Topics: Aged; Angina Pectoris; Aspirin; Female; Gene Expression Regulation; Glycophorins; Hemorrhage; Humans | 2008 |
[Coronary artery bypass grafting for simultaneous subacute stent thrombosis after sirolimus-eluting stent implantation].
Topics: Aged, 80 and over; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Restenosis; Coronary T | 2008 |
[Effects of medical therapy on long-term survival in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Anticoagulants; Aspirin; Calcium Channel Blocker | 1984 |
Serial angiographic evidence of rapid resolution of coronary artery stenosis.
Topics: Angina Pectoris; Angiography; Angioplasty, Balloon; Aspirin; Coronary Disease; Dipyridamole; Humans; | 1983 |
Unstable angina in a patient with mucocutaneous lymph node syndrome.
Topics: Aneurysm; Angina Pectoris; Angina, Unstable; Aspirin; Child; Coronary Angiography; Coronary Artery B | 1984 |
Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Aorta; Aspirin; Blood Pres | 1984 |
Role of thromboxanes in vasotonic versus vaso-occlusive angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Ca | 1983 |
The role of the platelets.
Topics: Adenosine Diphosphate; Angina Pectoris; Animals; Aspirin; Blood Platelets; Coronary Disease; Hemodyn | 1984 |
Aspirin and the risk of myocardial infarction.
Topics: Angina Pectoris; Aspirin; Humans; Male; Myocardial Infarction | 1984 |
Aspirin in the prevention of myocardial infarction. Current status.
Topics: Angina Pectoris; Aspirin; Cerebrovascular Disorders; Fibrinolytic Agents; Humans; Myocardial Infarct | 1984 |
Randomized surgical clinical trials for treatment of coronary artery disease.
Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Europe | 1982 |
Medical and surgical treatment of angina.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Female; Humans; Male; Middle Aged; Nitroglyc | 1981 |
[Problems of the operated patient and suggestions for their treatment].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As | 1982 |
Recent concepts on platelet function and dietary lipids in coronary thrombosis, vasospasm and angina.
Topics: Angina Pectoris; Arachidonic Acids; Aspirin; Constriction, Pathologic; Coronary Disease; Dietary Fat | 1980 |
Humoral heartache -- do platelets have a role?
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Aspirin; Blood Platelets; Coronary Circulation; | 1981 |
[Electron microscopic, histochemical and functional assessment of the effect of aspirin on the thrombocytes of healthy persons and ischemic heart disease patients].
Topics: Adult; Angina Pectoris; Aspirin; Blood Platelets; Coronary Disease; Histocytochemistry; Humans; Micr | 1982 |
[The treatment of chronic ischemic heart disease with acidum acetylsalicylicum in older patients (author's transl)].
Topics: Aged; Angina Pectoris; Aspirin; Cholesterol; Coronary Disease; Double-Blind Method; Humans; Male; Ri | 1980 |
[Spontaneous and repetitive angor pectoris. Temporary mitral insufficiency. Cessation of crisis under aspirin. Decline of fifteen months. Physiopathological and therapeutic considerations (author's transl)].
Topics: Aged; Angina Pectoris; Aspirin; Follow-Up Studies; Humans; Male; Mitral Valve Insufficiency | 1981 |
Platelet activation during exercise-induced myocardial ischemia.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Aspirin; Blood Coagulation Factors; Blood Platelets; Child | 1980 |
Platelets and ischemic heart disease.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Coronary Disease; Death, Sudden; Exercise Test; Humans; M | 1980 |
Platelet function studies in coronary artery disease. VII. Effect of aspirin and tachycardia stress on aortic and coronary venous blood.
Topics: Adult; Angina Pectoris; Aorta; Aspirin; Coronary Disease; Coronary Vessels; Humans; Middle Aged; Pla | 1980 |
Thromboxane receptor antagonist BMS-180291, but not aspirin, reduces the severity of pacing-induced ischemia in dogs.
Topics: Angina Pectoris; Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Pacing, Artifici | 1994 |
[Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Humans; Myocardial | 1994 |
[Use of aspirin in coronary disease].
Topics: Angina Pectoris; Anticoagulants; Aspirin; Coronary Disease; Dose-Response Relationship, Drug; Humans | 1995 |
Prescription of regular aspirin in patients with chest pain referred to a cardiology outpatient clinic.
Topics: Angina Pectoris; Aspirin; Cardiology Service, Hospital; Chest Pain; Drug Utilization; Family Practic | 1995 |
Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation.
Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; | 1995 |
[Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent].
Topics: Aged; Angina Pectoris; Anticoagulants; Antithrombin III; Aspirin; Blood Coagulation Factors; Female; | 1995 |
Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
Topics: Adult; Aged; Angina Pectoris; Anticoagulants; Antithrombin III; Aspirin; Female; Heparin; Humans; Ki | 1994 |
[Sliding indications for balloon angioplasty].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspi | 1994 |
[Drug treatment following an infarction].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anticoagulan | 1994 |
Impact of treatment with acetylsalicylic acid on the proaggregatory effects of adrenaline in vitro in patients with stable angina pectoris: influence of the anticoagulant.
Topics: Adenosine Diphosphate; Angina Pectoris; Aspirin; Citrates; Drug Synergism; Epinephrine; Female; Hiru | 1993 |
Oral verapamil inhibits platelet thrombus formation in humans.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Blood Pressure; Delaye | 1994 |
Clinical and angiographic determinants of initial percutaneous transluminal coronary angioplasty success.
Topics: Aged; Angina Pectoris; Angiography; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; | 1993 |
Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.
Topics: Adult; Aged; Angina Pectoris; Antithrombins; Aspirin; Cholesterol; Female; Humans; Hypercholesterole | 1996 |
The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator.
Topics: Angina Pectoris; Aspirin; Fibrin; Humans; Time Factors; Tissue Plasminogen Activator | 1995 |
Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Aspirin; Cell Adhesion; Coronary Disease; Dose- | 1996 |
N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation.
Topics: Acetylcysteine; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Drug Synergism; Female; Free | 1996 |
A prospective study of anger and coronary heart disease. The Normative Aging Study.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Anger; Angina Pecto | 1996 |
Current approaches to stable angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Aspirin; Humans; Hypolipidemic Agents; Middle Ag | 1996 |
Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls.
Topics: Adult; Aged; Angina Pectoris; Arousal; Aspirin; beta-Thromboglobulin; Exercise Test; Female; Hemodyn | 1997 |
Predictors of hospital readmission two years after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Aspirin; Coronary Artery | 1997 |
Stroke recurrence among 30 days survivors of ischemic stroke in a prospective community-based study.
Topics: Aged; Angina Pectoris; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Cohort Studies; Female; F | 1997 |
ASHP therapeutic position statement on the use of aspirin for prophylaxis of myocardial infarction.
Topics: Aged; Angina Pectoris; Aspirin; Female; Humans; Male; Middle Aged; Myocardial Infarction; Patient Se | 1997 |
Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Vessel Prosthesis Implantation; Coro | 1998 |
Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab.
Topics: Abciximab; Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; | 1998 |
Aspirin improves organic nitrate treatment for angina pectoris. Calcium channel antagonists do not decrease plasma inorganic nitrate levels.
Topics: Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Interactions; Humans; Isosorbide Dinitrate | 1998 |
Aspirin administration for cardiac-related acute chest pain/angina: increased use in Medicare patients.
Topics: Acute Disease; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Critical Pat | 1999 |
The management of stable angina.
Topics: Angina Pectoris; Angioplasty, Balloon; Aspirin; Cardiovascular Agents; Coronary Artery Bypass; Evide | 1997 |
Refining instructional text generation after evaluation.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Artificial Intelligence; Aspirin; Atenolol; Decision M | 1999 |
Aspirin and plasma interleukin-6 acute coronary syndromes.
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Humans; Interleukin-6 | 1999 |
[Ticlopidine-induced cholestasis].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Chemical and Drug Induced Liver Injury; Cholestas | 1999 |
Women with angina pectoris receive less antiplatelet treatment than men.
Topics: Aged; Angina Pectoris; Aspirin; Family Practice; Female; Humans; Male; Middle Aged; Myocardial Ische | 1999 |
Influence of SIN-1 on platelet Ca2+ handling in patients with suspected coronary artery disease: ex vivo and in vitro studies.
Topics: Angina Pectoris; Aspirin; Biological Transport; Blood Platelets; Calcium; Calcium Signaling; Catalas | 2000 |
Nonatherosclerotic aneurysm of the left circumflex coronary artery presenting with accelerated angina pectoris: response to medical management--a case report.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Anticoagulants; Aspirin; Coronary Aneurysm; Heparin; Huma | 2000 |
[ELAN study].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Data | 2000 |
[One-year follow-up of a population of patients with angina. Factors influencing mortality and occurrence of cardiovascular events. Results of the ELAN study].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Anti-Infl | 2000 |
Ticlopidine and aspirin fail to suppress the increased platelet aggregability that follows percutaneous coronary interventions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Blood Coagulation Tests; Coronary Angiography; | 2000 |
Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey.
Topics: Adult; Albuminuria; Angina Pectoris; Aspirin; Cardiovascular Diseases; Diabetes Complications; Diabe | 2001 |
[Late stent thrombosis after intracoronary brachytherapy. A case report and review of the literature].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Brachytherapy; Clinical Trials as Topic; C | 2001 |
Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
Topics: Angina Pectoris; Aspirin; Double-Blind Method; Fibrinolytic Agents; Humans; Multicenter Studies as T | 2001 |
[Spontaneous intraspinal epidural hematoma secondary to use of platelet aggregation inhibitors].
Topics: Angina Pectoris; Aspirin; Female; Hematoma, Epidural, Cranial; Humans; Laminectomy; Magnetic Resonan | 2001 |
Guidelines for the management of patients with chronic stable angina: treatment.
Topics: Adrenergic beta-Antagonists; Adult; Algorithms; Angina Pectoris; Aspirin; Calcium Channel Blockers; | 2001 |
Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angina Pectoris; Aspirin; Case-Control Stud | 2001 |
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Angioplasty, | 2001 |
Natural history of small and medium-sized side branches after coronary stent implantation.
Topics: Acute Disease; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary An | 2002 |
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.
Topics: Abciximab; Aged; Angina Pectoris; Antibodies, Monoclonal; Aspirin; Biomarkers; Creatinine; Female; H | 2002 |
Platelet function and myocardial injury during percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Aspirin; Biomarkers; Cardiac Surgical Procedures; Female; Humans; Intraoperat | 2002 |
[Prinzmetal's angina. Considerations on a clinical case].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Electrocardi | 1977 |
The effect of heparin and acetysal on blood platelet functions in coronary sclerosis.
Topics: Adult; Angina Pectoris; Aspirin; Blood Platelets; Coronary Disease; Heparin; Humans; Myocardial Infa | 1978 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrin | 1978 |
[Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Coronary Disea | 1978 |
Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study.
Topics: Adult; Aged; Angina Pectoris; Arthritis, Rheumatoid; Aspirin; Cerebrovascular Disorders; Coronary Di | 1978 |
[Platelet aggregation before and after exertion in subjects with infarction in the rehabilitation phase].
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Aspirin; Exercise Therapy; Humans; Male; Middle Aged; | 1978 |
Peripheral venous platelet aggregates in patients with unstable angina pectoris and acute myocardial infarction.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Angina Pectoris; Aspirin; Blood Cell Count; Female; Hum | 1977 |
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
Topics: Adenosine; Adult; Aged; Angina Pectoris; Apyrase; Arterial Occlusive Diseases; Aspirin; Coronary Dis | 1976 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coro | 1976 |
[Therapy of coronary disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Clinical Trials as | 1992 |
[The combination of taking acetylsalicylic acid and a complex of physical factors in the rehabilitative treatment of patients with ischemic heart disease].
Topics: Angina Pectoris; Aspirin; Combined Modality Therapy; Humans; Myocardial Ischemia; Physical Exertion; | 1992 |
[Acute myocardial injury and repeated angina pectoris-like attacks in a young patient with Churg-Strauss syndrome].
Topics: Adult; Age Factors; Angina Pectoris; Aspirin; Asthma; Churg-Strauss Syndrome; Eosinophilia; Humans; | 1991 |
[Effect of intravenous administration of aspisol on hemostasis and pain syndrome in patients with progressive angina].
Topics: Aged; Angina Pectoris; Aspirin; Female; Hemostasis; Humans; Lysine; Male; Middle Aged; Platelet Aggr | 1991 |
[New-onset angina pectoris: clinical aspects, diagnosis, prognosis and treatment tactics].
Topics: Angina Pectoris; Aspirin; Calcium Channel Blockers; Electrocardiography; Exercise Test; Humans; Midd | 1991 |
Early public use of aspirin in the face of probable ischaemic chest pain.
Topics: Angina Pectoris; Aspirin; Death, Sudden; Humans; Myocardial Infarction; Time Factors | 1990 |
Coronary angioplasty for medically refractory unstable angina in patients with prior coronary bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary | 1990 |
Therapeutic interventions which may improve survival in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Aspirin; Coronary Artery Bypass; Cor | 1990 |
[Adhesive activity of blood platelets in patients with stable or unstable angina pectoris and acute myocardial infarct].
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Creatine Kinase; Humans; Male; Microscopy, | 1991 |
[Expediency of long-term anti-angina therapy and physical exercises in patients with angina pectoris and a history of myocardial infarction].
Topics: Adult; Angina Pectoris; Aspirin; Exercise Therapy; Humans; Male; Middle Aged; Myocardial Infarction; | 1990 |
Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina.
Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Bleeding Time; Blood Platelets; Chest Pain; Epinep | 1990 |
Defective coronary prostaglandin modulation in anginal patients.
Topics: Adult; Angina Pectoris; Aspirin; Blood Pressure; Cold Temperature; Coronary Vessels; Female; Humans; | 1990 |
[Unstable stenocardia: various problems of pathogenesis and treatment].
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Constriction, Pathologic | 1989 |
Aspirin, heparin, or both to treat unstable angina.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Heparin; Humans; Myocardial Infarction | 1989 |
[Antiplatelet effects of combined therapy with ticlopidine and low doses of aspirin on patients with ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Aspirin; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Ag | 1989 |
Aspirin, nifedipine, and cataract.
Topics: Angina Pectoris; Aspirin; Cataract; Humans; Nifedipine | 1986 |
[Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Aspirin; Dipyridamole; Drug Therapy, Comb | 1986 |
Unstable angina revisited once more.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Combi | 1986 |
Management of patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Cardiac Cat | 1987 |
Use of percutaneous transluminal coronary angioplasty and bypass surgery despite improved medical therapy for unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Calci | 1988 |
Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology.
Topics: Aged; Angina Pectoris; Angiography; Aorta; Aspirin; Blood Specimen Collection; Coronary Circulation; | 1989 |
Coronary angioplasty in refractory unstable angina.
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Coronary Vessels; Humans | 1986 |
Aspirin for unstable angina?
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Humans; Myocardial Infarction; Platelet Aggregation; Pro | 1986 |
[Hemodynamic effects of nitroglycerin following acute inhibition of prostaglandin synthesis].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Angina Pectoris; Aspirin; Cyclooxygenase Inhibitors; Dinoprosto | 1986 |
Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Arachidonic Acid; Arachidonic Acids; Aspirin; Bloo | 1987 |
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinatio | 1988 |
Protective effects of the antianginal agent nicorandil on arachidonate-induced sudden death in rats: comparison with several antianginal agents and cyclooxygenase inhibitors.
Topics: Angina Pectoris; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; D | 1985 |
Clinical experience of percutaneous transluminal coronary angioplasty--technique and results.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; | 1985 |
[Effect of various drugs on rheological properties of the blood and hemostasis in patients with unstable stenocardia].
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Blood Viscosity; Female; Hemostasis; Humans | 1987 |
The consent form as a possible cause of side effects.
Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Digestive System; Humans; Informed Consent; Plac | 1987 |
Dissolution of angiographically detected intracoronary thrombus for unstable angina pectoris after aspirin therapy.
Topics: Aged; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Coronary Disease; Coronary Thrombosis | 1987 |
[Effect of hemosorption and the separate and combined use of obsidan, trental and colpharit on rheological and hemostatic properties of the blood in patients with unstable stenocardia].
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Blood Viscosity; Combined Modality Therapy; | 1986 |
Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Aspirin; Cardiac Pacing, Artificial; Coronary Ci | 1985 |
Anticoagulants: a guide for practitioners.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Dicumarol; Disseminated Intravascular Coagulation; Electri | 1973 |
[Differential treatment of coronary heart disease].
Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; H | 1974 |